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Cardiovascular disease (CVD) is the leading cause of death in many regions 
worldwide, accounting for nearly one third of global deaths in 2001.  Wearable 
electrocardiographic cardiovascular monitoring devices have contributed to reduce 
CVD mortality and cost by enabling the diagnosis of conditions with infrequent 
symptoms, the timely detection of critical signs that can be precursor to sudden 
cardiac death, and the long-term assessment/monitoring of symptoms, risk factors, 
and the effects of therapy.  However, the effectiveness of ambulatory 
electrocardiography to improve the treatment of CVD can be significantly impaired 
by motion artifacts which can cause misdiagnoses, inappropriate treatment decisions, 
and trigger false alarms.  Skin stretch associated with patient motion is a main source 
of motion artifact in current ECG monitors.  A promising approach to reduce motion 
artifact is the use of adaptive filtering that utilizes a measured reference input 
  
correlated with the motion artifact to extract noise from the ECG signal. Previous 
attempts to apply adaptive filtering to electrocardiography have employed either 
electrode deformation or acceleration, body acceleration, or skin/electrode impedance 
as a reference input, and were not successful at reducing motion artifacts in a 
consistent and reproducible manner. This has been essentially attributed to the lack of 
correlation between the reference input selected and the induced noise. 
In this study, motion artifacts are adaptively filtered by using skin strain as the 
reference signal.  Skin strain is measured non-invasively using a light emitting diode 
(LED) and an optical sensor incorporated in an ECG electrode.  The optical strain 
sensor is calibrated on animal skin samples and finally in-vivo, in terms of sensitivity 
and measurement range.  Skin stretch induced artifacts are extracted in-vivo using 
adaptive filters.  The system and method are tested for different individuals and under 
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Chapter 1: Non-invasive Ambulatory Monitoring of 
Cardiovascular Disease 
 
1.1   Introduction 
Cardiovascular disease (CVD) is the leading cause of death in many regions 
worldwide, accounting for nearly one third of global deaths in 2001 (American Heart 
Association 2005b), and as much as 40% of deaths in the United States (US) and the 
European Union (EU) (American Heart Association 2005a, Petersen et al. 2005).  In 
the US, when considered as either a primary or contributing cause, CVD mortality 
represents nearly 60% of all mortality (American Heart Association 2005a).  In 
addition, 32% of deaths from CVD are premature deaths (i.e., before the average life 
expectancy) (American Heart Association 2005a).  The total yearly cost of CVD has 
been projected to reach US $394 billion in the US this year (American Heart 
Association 2005a), and is currently estimated to be over US $169 billion in the EU 
(Peterson et al. 2005).   
The two most frequent forms of CVD are coronary heart disease (CHD)1 and 
stroke (also termed cerebrovascular disease), which alone cause 53% and 18% of 
CVD-induced deaths in the US, respectively (American Heart Association 2005a).  
Other common types of CVD include congestive heart failure2, high blood pressure, 
                                                 
1 Coronary heart disease involves a reduction in the blood supply to the heart muscle by narrowing or blockage of the coronary 
arteries (atherosclerosis). In time, inadequate supply of oxygen-rich blood and nutrients damages the heart muscle and can lead 
to myocardial infarction (heart attack) and angina pectoris (chest pain). 
2 Condition resulting from weakness of the heart muscle, in which the heart cannot pump out all of the blood that enters it. This 
results in an accumulation of blood in the vessels leading to the heart and fluid in various parts of the body such as the lungs, 




and diseases of the arteries (American Heart Association 2005a).  Such conditions are 
chronic diseases, or wearout mechanisms from a reliability engineering viewpoint.  
The elderly (age 65 or older) carry a higher risk of CVD-induced death 
compared with the rest of the population, and represent 39% of all patients affected 
by CVD in the US (American Heart Association 2005a).  The aging of the population, 
which will lead to 40 million Americans being aged 65 or older by 2010 (American 
Heart Association 2005a), will result in an increased incidence of chronic CVDs.  
CVD also represents the second largest cause of death in the US population aged less 
than 15.  While most CVDs in children are due to congenital cardiovascular 
malformations, an increasing number of children are developing risk factors including 
high blood pressure, smoking, high blood cholesterol, physical inactivity, overweight, 
and the metabolic syndrome3.  Furthermore, it is anticipated that cardiovascular 
complications resulting from other conditions, namely obesity and type 2 diabetes, 
which are affecting a growing portion of the population, will contribute to further fuel 
the cardiovascular outbreak for years to come (American Heart Association 2005a).   
In this context, progress in early, accurate and cost-effective diagnosis and 
assessment of chronic CVDs, and their prevention, are becoming critical to improve 
life expectancy and reduce the economic toll of CVD.  It is estimated that if all forms 
of major CVD were eliminated, life expectancy in the US would rise by almost seven 
years (American Heart Association 2005a). 
Although current medical and clinical approaches of CVD assessment can 
provide direct and accurate evidence of heart disease, these techniques only provide 
                                                 
3 Abnormal levels for three or more of the following factors: waist 




periodic (intermittent) assessment of the disease.  Considering that the majority of 
cardiac deaths are sudden deaths, which occur before the patient can reach a medical 
care facility (Center for Disease Control and Prevention 2002), there is a need for out-
patient continuous CVD monitoring to enable the timely detection of precursor 
symptoms to sudden death, and to enable the long-term management of chronic 
conditions through monitoring of symptoms, risk factors, and regimen compliance.  
Conversely, a large portion of patients surviving a heart attack require potentially 
risky and costly invasive procedures such as coronary angioplasty4 or coronary artery 
bypass surgery.  Such procedures could be avoided by continuous CVD monitoring, 
which could prevent hospitalization through the timely detection of critical 
symptoms.   
Clinical techniques such as echocardiography and MRI are operationally 
complex and require physically large equipments, and are therefore not suitable for 
use in rural areas, primary healthcare facilities and homecare (Pavlopoulos et al. 
2004).  Portable or wearable monitoring cardiac devices can supplement traditional 
medical care by assisting the follow up and treatment of patients with heart disease, 
particularly the elderly who require more frequent cardiac assessment, and for whom 
traveling to a clinical care facility may be difficult and costly.  The use of cardiac 
health monitoring has also been proposed for professional categories whose access to 
medical care is restricted by geography or environment (Scanlon 1998). 
This chapter assesses current and emerging non-invasive ambulatory CVD 
monitoring techniques.  The requirements, challenges, applications, and perceived 
                                                 
4 Invasive procedure performed to reduce or eliminate blockages in coronary arteries. A catheter is guided into the clogged heart 
artery from an artery in the leg or arm. An expandable balloon is passed to the blockage and inflated to push against the plaque 




medical value of the monitoring technologies presented are analyzed.  Ambulatory 
electrocardiographic and blood pressure monitors are generally considered the most 
mature technologies (Liu et al. 2005).  While sensing techniques for blood perfusion, 
oxygen saturation, cardiac sound, and vascular blood velocity have been implemented 
in standard clinical devices, ambulatory applications are still at early prototyping 
phase.  Multiparameter cardiovascular monitors, typically in the forms of clothing, 
have recently appeared and are introduced.    
 
1.2   Electrocardiography 
The electrocardiogram (ECG)5 is currently the most widely prescribed 
medical diagnostic procedure.  The main diagnostic applications of the clinical ECG 
are arrhythmia6, cardiac myopathies7, and coronary blood flow abnormalities (Guyton 
and Hall 2000).  In addition, electrocardiography is also used to evaluate the effects 
of medication and monitor patients during surgery.   
A typical ECG waveform is shown in Figure 1, and is composed of a P wave, 
a QRS complex (which is comprised of Q, R and S waves), and a T wave (Guyton 
and Hall 2000).  The P wave is produced by atrial depolarization, the QRS complex 
primarily by ventricular depolarization, and the T wave by ventricular repolarization 
(Webster 1998).  The significant features of the waveform are the waves and their 
individual durations, and time intervals including the P-R, S-T and Q-T intervals 
                                                 
5 An electrocardiogram (ECG) is a graphic recording of the body-surface electrical potentials generated by electrical activation 
of the ventricular and atrial muscles (Webster 1998).  Their activation involves sequential polarization and depolarization of the 
myocardial cells, that produce closed-line action currents that flow in the thoracic volume conductor (Webster 1998).  A small 
portion of the currents spreads to the surface of the body.   
6 Abnormal heart rhythm. 




(Webster 1998).  The amplitude of the ECG is normally 0.1 to 3 mV, with a 
frequency range of 0.05 to 100 Hz (Smith 1984).   
 
 
Figure 1. Typical clinical scalar ECG 
 
In electrocardiography, the difference in electrical potential between specific 
sites on the skin is measured using electrodes (Guyton and Hall 2000) that transduce 
cutaneous ionic current into electronic current to measure biopotentials (Webster 
1998).  The electrodes are typically metal plate, silver/silver chloride (Ag/AgCl) 
electrodes that are attached to the skin using adhesive pads.  An electrolyte paste or 
gel containing chloride anions is used to establish electrical contact between the 
electrode and the skin (Webster 1998).     
Clinical and ambulatory electrocardiographs differ in terms of the number of 
leads8, and data storage, processing, transmission, and reporting format.  Clinical 
electrocardiographs employ twelve leads, usually six in the frontal plane9 and six in 
the transverse plane10(Webster 1998), with a total of ten electrodes.  Advances in 
signal processing techniques and computational power have enabled the use of 
                                                 
8 Pair of electrodes used to measure the potential difference between two sites.   
9 Plane of the body parallel to the ground when the patient is laying on his/her back.  The six frontal leads consist of three basic 
leads (left arm to right arm, left leg to right arm and left leg to left arm) that form Eindhoven’s triangle, and three augmented 
leads (also referred to as Golberger’s leads), which are functions of the three basic leads (Webster 1998).   
10 Plane of the body parallel to the ground when the patient is standing plane of the body parallel to the ground when the patient 
is standing.  The six transverse leads are six precordial (chest) leads that each consist of an electrode referenced to a common 




computerized ECG interpretation.  Although useful for the precise calculation of 
certain ECG characteristic parameters, the overall diagnostic accuracy of such 
interpretation programs still requires improvement (Kadish 2001).   
Ambulatory ECG monitors can be classified as either continuous (Holter 
monitors) or intermittent recorders (ECG event monitors or episodic monitors) 
(Kadish 2001, Kowey and Kocovic 2003, Zimetbaum and Josephson 1999).  Their 
main application is the diagnosis of intermittent arrhythmia11 that can remain 
undetected in a clinical examination, since certain abnormalities may occur only 
during sleep or with mental, emotional, or exercise induced changes in cardiac 
oxygenation or function (Kadish 2001).  Ambulatory ECG monitors also permit the 
occurrences of abnormal cardiac electrical behaviour to be characterized while the 
patient is pursuing his/her normal activities, which is not feasible by clinical 
electrocardiography.  It has been estimated that of the 88 electrocardiographic 
diagnoses that can be made from a 12-lead ECG, up to 63 can be performed using 
ambulatory electrocardiography (Kadish 2001).  In terms of prognosis, Zimetbaum 
and Josephson (1999) note that guidelines are lacking on the use of ambulatory 
monitors for prognosis in patients at potential risk of sudden arrhythmic death.   
The Holter monitor was developed in the 1960’s to continuously record ECG 
data for 24 to 48 hours.   Apart from the detection of intermittent arrhythmic 
symptoms, continuous monitoring is also used to assess antiarrhythmic or 
concomitant drug therapy12 response, to survey patients with implanted pacemakers 
or cardioverter defibrillators (ICDs), including potential device failure, and can assist 
                                                 
11 Abnormal heart rhythm. 




in the screening and therapy of silent myocardial ischemia13 (Kadish 2001, Virginia 
Mason Medical Center 2000).  The number and position of the electrodes varies with 
the model, but most Holter monitors employ two to three leads attached to the chest 
(Kowey and Kocovic 2003).  The data is recorded on either a tape, flash card or disk, 
with no patient activation required, and is analyzed offline (Kowey and Kocovic 
2003).  The patient records his/her activities and any detectable symptoms (e.g., 
faintness, dizziness) in a diary, so that this information can be subsequently correlated 
with the ECG data.  The main limitation of the traditional Holter monitor is that the 
recording time can be too short to capture infrequent arrhythmia, due to memory 
constraints (Zimetbaum and Josephson 1999).  It is estimated that in general, only 
10% of arrhythmias that are suspected from symptoms are detected (Kowey and 
Kocovic 2003).  Extending the period of observation requires serial recordings, which 
is currently considered impractical and costly14 (Kowey and Kocovic 2003).  In 
addition, the recorder size can interfere with normal activities and prevent exercise 
that may trigger rhythm abnormalities to be detected (Zimetbaum and Josephson 
1999).  Also, patients frequently forget to document the timing of their symptoms, 
which can impact the specificity of the ECG interpretation (Zimetbaum and 
Josephson 1999). 
ECG event monitors serve to evaluate infrequent symptoms via continuous 
monitoring over periods of up to three months, but recording is intermittent (Kadish 
2001).  Event monitors can be classified as either post event recorders, loop recorders, 
or mobile cardiac outpatient telemetry systems.  In traditional post event recorders, 
                                                 
13 Inadequate supply of oxygen-rich blood to the heart that does not cause symptoms such as chest pain. 
14 A Holter monitor (hardware) typically costs several thousand US dollars (MedFirst Healthcare Supply, Inc.).  Patient cost for 




recording is manually triggered when abnormal symptoms are detected by the patient.  
The recorded ECG is stored and subsequently transmitted by telephone to a base 
station.  Such monitors can combine one pair of electrodes (one lead) with the 
recorder in a single unit, in the form of a credit card-size patch (Charuvastra 1998) 
that can be carried in the pocket and held to the chest for recording, or wrist watch 
type device (Mona-System Ltd., LifeWatch 2004).  Wrist watch recorders have one 
electrode on the back of the watch and the other electrode beside the display, with the 
circuit completed by the application of the opposite hand over the display-side 
electrode.  Such systems provide up to ten or fifteen minutes single channel 
recording, and the data can be transferred to a personal computer (PC) via an optical 
cable or standard modem (Mona-System Ltd., LifeWatch 2004).  Concerns have been 
expressed that the quality of the ECG signal recorded by wrist watch type event 
monitors, can be inconsistent and unreliable (Charuvastra 1998).  A major limitation 
of post event recorders is their inability to capture the initiation of or the period 
directly preceding the onset of arrhythmia (Zimetbaum and Josephson 1999), since 
triggering the data recording can be difficult for the patient when a symptom is in 
progress, particularly for elderly patients (Zimetbaum and Josephson 1999).  
Continuous-loop event recorders address this shortcoming by continuously recording 
and erasing electrocardiographic data, so that data measured from one to four minutes 
before, and 30 to 60 seconds after the device was activated can be stored (Kowey and 
Kocovic 2003).  This technology can enable very fleeting symptoms, tachycardia15 
onset, and in some cases, infrequent syncope16, to be captured (Kadish 2001).  The 
                                                 
15 Rapid heartbeat (typically in excess of 100 beats per minute). 




most common type of continuous-loop event monitors consists of a recorder (about 
the size of a beeper) that can be attached to the patient’s belt and two patch 
disposable, waterproof precordial electrodes (Zimetbaum and Josephson 1999) that 
are typically changed every three to four days (Charuvastra 1998).  Another solution 
is the use of automatically activated recorders, which employ algorithms to initiate 
recording upon the detection of an abnormal heart rhythm (Kowey and Kocovic 
2003).  A category of automatically activated recorders, referred to as mobile cardiac 
outpatient telemetry systems, are equipped with cellular-based transmission.  Upon 
the detection of abnormal heart rhythm by embedded algorithms, ECG data are 
transmitted automatically to a monitoring center, along with any symptoms and 
activity data recorded electronically by the patient (Cardionet 2002, Cleveland Clinic 
Heart Center 2003).  The system presented in (Cardionet 2002), for example, uses 
three wired precordial electrodes (i.e., two leads), and allows up to two weeks 
continuous monitoring.  Although promising, this technology requires further 
validation to quantify its potential to improve both the number of arrhythmia episodes 
detected and the rapidity of medical response (Kowey and Kocovic 2003).   
The use of current ECG monitors is generally considered too expensive, 
except for patients at high risk (Welch et al. 2004).  Focusing on the reduction of 
hardware costs to expand the availability of such devices, Welch et al. (2004) 
developed a single lead, wireless, wearable ECG monitor that integrates two 
electrodes, a system-on-chip microcontroller for low-rate data sampling, algorithmic 




ISM band17 transceiver.  The optimum position of the sensor was found to be a 
vertical orientation on the sternum.  The monitoring time of the device is limited by 
battery life (a pair of disposable lithium cells having an expected life of three days), 
or the time that adhesives will maintain sensor attachment to the skin.  The monitor is 
intended for heart rate recording and the detection of ventricular fibrillation18, 
ventricular tachycardia, and asystole19, as well as the assessment of pacemaker 
function.  Preliminary evaluation of sensor performance in the presence of electrode 
motion and muscle artifact was found to be promising.   
The performance of current electrocardiogram (ECG) monitors can be 
significantly degraded by motion artifacts, which is discussed in more depth in 
Chapter 2. 
In recent years, new types of electrodes have been developed. These include 
the fabric electrodes developed by Paradiso et al. (2005) and Scilingo et al. (2005), 
and various types of dry electrodes, including the non-contact electrical potential 
probe developed by Prance et al. (2000) and Harland et al. (2002, 2003), the non-
contact optical sensor developed by Kingsley et al. (2002, 2003, 2004) and Johnson 
(2003), and semi-invasive electrode using carbon nanotubes arrays developed by 
Ruffini et al. (2005).  The fabric electrodes can be embedded in a garment.  The dry 
electrodes have the advantage of easy applications, since the use of electrolytic gel 
and adhesive attachment is eliminated.  These are in the development stage and 
haven’t been used in clinical applications.  
                                                 
17 Unlicensed band (902 to 928 MHz) intended for low-data rate industrial, scientific, and medical communications, which is 
widely used for short-range wireless data links. 
18 Abnormally rapid, disorganized and inefficient contraction of muscle fibres of the heart. This condition is life-threatening. 




Paradiso et al. (2005) and Scilingo et al. (2005) developed conductive fabric 
electrodes imbedded in the clothing to make a comfortable garment capable of 
recording ECG signals.  The fabric electrodes were realized with stainless steel yarns 
twisted around a viscose textile yarn, with about 30% metal.  A hydrogel membrane 
was used to improve the contact between fabric and skin, and to improve the 
electrical signal quality in dynamic conditions with the presence of ions in the 
membrane.  Results showed that the signal obtained by the integrated systems is 
comparable with that obtained by standard electrodes.   
As an alternative to the Ag/AgCl electrodes that have relatively low 
impedance (106 to 107 Ohms) and sensitivity, and require direct electrical contact 
with the skin through an electrolytic paste and adhesive attachment, Prance et al. 
(2000) and Harland et al. (2002, 2003) developed a high input impedance (1015 
Ohms) electrical potential probe that detects a displacement current instead of a 
charge current, and uses feedback enhanced and stabilized electrometer based 
amplifiers.  Such probes can be operated in either mechanical (but not electrical) 
contact mode whereby coupling with the body signal is formed via electrode-body 
interfaces, or remote off-body mode whereby the probe forms capacitive coupling 
with the body.  In contact mode, both the probe noise floor level (70 nV Hz-0.5 at 1 
Hz), and inherent lack of cross coupling between closely spaced electrodes (as would 
occur between conventional electrical contact electrodes through leakage currents), 
enable the detection of low-amplitude biopotentials.  Prance et al. (2000) and Harland 
et al. (2002, 2003) could measure detailed features of the ECG (namely, His-Perkinje 




surface ECG.  (The His-Perkinje discharge peak is generally measured using an 
intracardiac catheter).  Other envisaged low level biopotential measurement 
applications include fetal heart beat (10 μV at a few Hz) and electroencephalograms20 
(10 to 40 μV at a few Hz).  The use of a differential signal provided by two probes 
(e.g., attached to left and right hand fingers) was found to significantly reduce 
electromyographic and other body noise sources that can affect single probe 
measurements.  The prototype monitor developed in (Harland et al. 2003) uses two 
probes individually mounted in two wristwatch type housings, a wireless radio 
transmitter and a receiver located at a distance of one to ten meters from the 
transmitter.  Although promising, this technology requires further evaluation, 
including the susceptibility to artifacts.  In remote mode, (Harland et al. 2002) and 
(Prance et al. 2000) could measure heart beats at a distance of up to one meter from a 
clothed body, which could open up new biopotential sensing applications.  
Another type of non-contact ECG sensor was developed by Kingsley et al. 
(2002, 2003, 2004) and Johnson (2003).  The sensor, named PhotrodeTM, is a 
miniature, optical chip that consists of a specially designed integrated optical circuit.  
The optical sensor uses photons to detect and measure the body’s bioelectric voltages, 
including ECG and EEG (electroencephalogram).  The output optical signal of a 
superluminescent diode enters the sensor, and the biopotential signal ECG or EEG 
changes the phase of the light propagating in the sensor and converts it to intensity 
modulation.  The modulated light is conveyed by optical fibre to an optical receiver, 
where the ECG or EEG signal is converted back to the electronic regime, and 
interpreted with signal processing.  ECG / EEG data obtained using PhotrodeTM is 
                                                 




claimed to comparable to that obtained from conventional electrodes.  The main 
advantage of the optical sensor is to eliminate the need for troublesome electrode 
attachment, since the sensor does not require physical contact to the body and can be 
placed over the subject’s clothing to measure ECG.  The technology is especially well 
suited in functional magnetic resonance imaging (MRI) of the heart or brain, since the 
sensor system is not sensitive to electromagnetic interference.  The major technical 
challenge includes interferometric fibre optic lead noise caused by minute optical 
reflections (Kingsley et al. 2002, 2003, 2004, Johnson 2003).  
Ruffini et al. (2005) developed a dry electrode with the contact surface 
covered with an array of carbon nanotubes.  The nanotubes form a brush-like 
structure and penetrate the outer layer of the skin, the stratum corneum, to acquire 
biopotential signal.  The invasive effect is negligible since the size of the nanotubes is 
much smaller than the pores of the skin, and the nanotubes barely penetrate the 
outmost layer of the skin, which avoid contact with nerve cells in deeper skin layers.  
The application of the nanotube electrode can eliminate the need for skin preparation 
and gel application, but its biocompatibility needs further investigation.    
 
1.3   Blood Pressure Monitor 
Two types of blood pressure21 (BP) monitors are currently available on the 
market, namely self-measured and ambulatory BP monitors.  Self-measured BP 
monitors require recording to be initiated by the patient, and are suitable for home 
                                                 
21 In blood pressure measurement, the pressure of blood flowing through the blood vessels against the artery walls is recorded.  
A blood pressure reading consists of two values (e.g., 120/80 mmHg).  The first value represents systolic blood pressure, and 
reflects arterial pressure during systole (part of the cardiac cycle during which the heart muscle contracts to force blood into the 
arteries).  The second value is diastolic blood pressure, and represents arterial pressure during diastole (i.e., relaxation or filling 




use.  Ambulatory BP monitors typically provide up to 24 hours of intermittent, 
automated BP recording, including during sleep states.  The measurement frequency 
is normally every 15 to 30 minutes.  The data (50 to 100 readings per 24 hours) stored 
in the monitor can be subsequently downloaded to a computer.   
Ambulatory BP monitors have greatly contributed to research on 
hypertension22.  The most common application of BP monitoring is the diagnosis of 
white coat hypertension23 (Appel et al. 2002, McGrath 2002, Marchiando and Elston 
2003).  Other applications include therapy monitoring and diagnostic applications 
including nondipping BP pattern, apparent drug resistance, hypotensive symptoms to 
medications, episodic hypertension, and autonomic dysfunction (Appel et al. 2002, 
McGrath 2002, Marchiando and Elston 2003).  The majority of ambulatory BP 
monitors in the market mainly utilize one of two sensing mechanisms, namely the 
auscultatory or oscillometric method.  Other methods include volume clamp method, 
tonometry method, and the use of the correlation of blood pressure and pulse velocity 
signal.  
In the auscultatory method (McGrath 2002, Marchiando and Elston 2003) a 
cuff secured around the upper arm is inflated above systolic pressure, to totally 
occlude the brachial artery24.  The cuff is slowly deflated, and systolic pressure is 
measured at the onset of the first Korotkoff sound25, which is detected through 
                                                 
22 High blood pressure.  Hypertension is a common risk factor for cardiovascular disease.  Fifty million Americans have 
hypertension, which accounts for approximately 25% of the adult US population (Appel et al. 2002).   
23 Condition in which the patient has elevated BP during medical examination, but otherwise normal BP.  White coat 
hypertension is also called isolated clinic hypertension, non-sustained hypertension, or office hypertension.  Patients with white 
coat hypertension represents 20 to 30% of the patients who have high BP during medical examination.  However, white coat 
hypertension presents a significantly lower health risk than sustained BP elevation.   
24 Main artery of the upper arm, located on the inside of the arm. 




auscultation using a microphone placed downstream of the cuff.  Diastolic pressure is 
determined when the Korotkoff sounds cease.  
The cuff oscillometric method (McGrath 2002, Marchiando and Elston 2003) 
is based upon the detection of cuff pressure oscillations at the brachial artery that are 
caused by vibrations in the arterial wall.  Both systolic and mean arterial pressure are 
directly measured, and used to calculate diastolic pressure using one of several 
algorithms, depending upon the manufacturer (Marchiando and Elston 2003).  The 
cuff pressure at the onset of the rise in pressure oscillations is generally recorded as 
systolic pressure.  The cuff pressure at the point of maximum amplitude of the cuff 
pressure oscillations corresponds to the mean arterial pressure.   
In the volume clamp method (Penaz 1973, Molhoek et al. 1981), the pressure 
of a finger-mounted cuff is continuously adjusted to equal (follow) intravascular 
blood pressure, resulting in constant vascular volume.  Arterial volume is measured 
by plethysmography26.  BP monitors utilizing this sensing technique are referred to as 
Portapres and its corresponding non-portable product is called Finapres.   
Tonometry is a non-invasive method to measure arterial pressure by applying 
an array of pressure transducers on the wrist.  A pneumatic pump and bellows press 
the transducers on the skin surface which partially flattening an artery to a bone 
surface.  This pressure is less than arterial pressure therefore the artery is not 
occluded.  The transducer recording the largest amplitude cardiac pulsations is 
determined automatically from the array and used to record arterial pressure 
waveforms.  The system is calibrated with systolic and diastolic measurements from a 
standard arm cuff oscillometric method (Sato et al. 1993, Colin).  This method 
                                                 




requires the sensor to be fixed on the wrist during continuous recording since it is 
susceptible to motions and sensor position change.  
In the pulse velocity method, pulse signals are detected from two different 
locations on the subject’s body by impedance plethysmograph sensor (Peterson 2004) 
or optoelectric sensors (Chen et al. 2003, 2005).  The elapsed time between the 
arrivals of the corresponding points of the pulse signal at these two locations is 
determined and used to derive blood pressure.  Shaltis et al. (2004) developed a 
method of cuffless BP monitoring that combines two reflective 
photoplethysmograph27 (PPG) sensors attached to the ring finger of each of the two 
hands, with a hydrostatic pressure reference approach to calibrate the sensors.  The 
obtained compliance curve between vascular volume and transmural pressure is used 
to derive BP from the plethysmographic measurements. 
In clinical practice, BP is normally non-invasively measured on the brachial 
artery using either the auscultatory or cuff oscillometric method.  Consequently, the 
majority of medical studies of blood pressure have been conducted with BP measured 
at that site.  Generally, the more peripheral the measurement site, the higher the 
systolic BP and the greater the difference between systolic and diastolic pressure 
(Braun.com 2000).  Therefore, measurements obtained from fingers or wrists are not 
equivalent to those obtained using traditional upper arm measurements.  For this 
reason wrist / finger monitors have not been widely used due to lack of knowledge on 
the interpretation of wrist / finger ECG data, and lack of methods to accurately 
correlate wrist / finger ECG data with upper arm data.  
                                                 
27Photoplethysmography (PPG), or photoelectric plethysmography is a noninvasive optical technique for measuring tissue blood 




Areas for improvement in ambulatory blood pressure monitoring include the 
effect of cuff size on BP measurement accuracy, motion and posture-induced 
artifacts, patient tolerance, and cost, which is typically several thousands dollars for 
the hardware (Appel et al. 2002).  
For the majority of BP monitors in the market, which are utilizing either 
auscultatory or oscillometric method, the use of a sufficient cuff length and width is 
critical for adequate compression of the brachial artery, as insufficient cuff size can 
lead to overestimation of BP (Kmom 2003).  Although the importance of using a 
correctly sized cuff has been documented for over twenty years, this is still one of the 
most common sources of measurement error encountered with obese patients (Kmom 
2003).  Ng and Small (1993) showed by both experimental and analytical analysis 
that cuff-arm compliance and bladder size interact to affect the pulse amplitude, 
hence oscillometric BP measurements.  A numerical study (Cristalli et al. 1994) 
indicates that apart from cuff size, the periarterial pressure imposed by an external 
cuff also depends on various factors including elastic properties of the arm soft 
tissues, and arterial position.  In addition, traditional BP monitors with cuffs can 
interfere with daily activities and sleep (Staessen et al. 1995, Asada et al. 2003).  
The performance of portable BP monitors in ambulatory conditions, during 
physical exercise or for patients whose cardiac rate is irregular (e.g., as in arterial 
fibrillation) has not been fully characterized (Staessen et al. 1995, McGrath 2002).  A 
generally acceptable rule is that a BP recording is not acceptable if less than 85% of 
the readings are usable (McGrath 2002).  Methods investigated to reduce artifact 




filter artifact-contaminated BP measurement segments (McGrath 2002, Protocol 
Systems Inc., Chittenden and Weaver 1988), and the use of fuzzy-logic-based 
recursive weighted regression algorithms (Lin et al. 2003).   
The use of ambulatory BP monitors has been controversial (Appel et al. 
2002).  Concerns have been raised that ambulatory BP monitors may be overutilized 
(Appel et al. 2002).  In general, medical practices do not consider it necessary to 
repeat ambulatory BP measurements more than once a year, but patient monitoring 
needs are highly patient specific and depend upon a number of factors (O’Brien et al. 
2000).  While the estimation of BP from multiple measurements has been found to be 
a more sensitive indicator of cardiovascular outcome than occasional recordings 
(O’Brien et al. 2000), the capability of BP monitors to provide information than can 
supplement clinical measurements has been questioned (Appel et al. 2002).  Also, it is 
still unclear whether self-measured BP monitoring is a satisfactory and less expensive 
alternative to ambulatory BP monitoring.  Consequently, insurers have been reluctant 
to reimburse costs for the use of ambulatory BP monitors (Appel et al. 2002).  
 
1.4   Photoplethysmograph and Pulse Oximeter 
Photoplethysmography (PPG) is used to indicate the volume change in blood 
perfusion by an optical method.  The intensity of light generated by a light emitting 
diode (LED) is transmitted through or reflected by the tissue, with the received signal 
indicating the volume change in blood perfusion.  There are two types of PPG, 




The most important parameter for practical use of photoplethysmograph is the 
venous refilling time after finishing a standardized exercise of the calf muscles 
(Veraart et al. 1994).  Photoplethysmography can also be used to diagnose arterial 
diseases in fingers and toes, and functional disturbance of blood flow, and has been 
widely used in commercial pulse oximetry to measure oxygen saturation.  In addition, 
PPG can provide a means to measure peripheral blood pressure. 
Pulse oximetry is a method of measuring oxygen saturation28 of the arterial 
blood based on the absorption of specific wavelength of light by a blood specimen.  
An oximeter detects hypoxia (lack of oxygen supply to tissues) before the patients 
become clinically cyanosed (the skin looks blue due to lack of oxygen supply).  
Audible alarms can be provided by programming (Fearnley 1995).  Pulse oximetry is 
now a standard practice in anesthesiology indicating the patients’ cardio-respiratory 
status, and has also been successfully used in intensive care and the recovery room 
(Welch et al. 1990, Hill and Stoneham 2000).   
A pulse oximeter consists of a probe, which is attached to the patient’s finger 
or ear lobe, and a microprocessor unit for displaying the oxygen saturation and the 
pulse rate (Hill and Stoneham 2000).  Two light emitting diodes (LED’s) are within 
the probe.  One light is in the visible red spectrum (660nm) and the other in the 
infrared spectrum (940 nm) (Hill and Stoneham 2000).  The beams of light pass 
through the tissue to a photodetector and some light is absorbed by the blood and soft 
tissues.  The amount of light absorbed by haemoglobin at each light frequency defers 
depending on whether it is saturated or desaturated with oxygen (Fearnley 1995, Hill 
                                                 
28 Oxygen saturation is the average percentage of saturation of a population of haemoglobin (oxygen transporting blood cell 




and Stoneham 2000).  By calculating the absorption at the two wavelengths the 
proportion of oxygenated haemoglobin is computed (Hill and Stoneham 2000).  Pulse 
oximeters are available in the market produced by Biox and Nellcor etc (Welch et al. 
1990) and the portable devices have been commercialized. 
Efforts are on-going to develop ambulatory PPG monitors, though to date 
none of these devices are commercialized.  Ambulatory PPG monitors have the 
advantages of easy operating, small size and low cost.  However, the diagnostic value 
for long term monitoring needs to be further studied.  
In 1995 Yamashita et al. (1995) developed a ring type telemeter that allows 
continuous vital sign monitoring and wireless data transmission.  The technique is 
based on radio telemetry of PPG signal detected at the finger on which the ring is 
applied, and automatic alarming.  A telemetry transmitter was made in the shape of a 
finger ring so that it can be easily installed.  PPG signals were detected at the finger 
by a pair of LED’s and a photodiode installed in the ring.  The signal was transmitted 
to a remote receiver located in a house using an FM carrier wave.  At the receiver, if 
the interval of the pulse becomes shorter or longer than a predetermined value, or the 
pulse amplitude become weak, an alarm system is activated.  The alarm system 
indicates an emergency by an alarm sound or by dialing an emergency telephone 
number automatically.  It was found that the signal amplitude was largely dependent 
on the positions of the LED and a PD.  Power consumption is also an important factor 
since it determines the dimension and the weight of the transmitter.    
In 1998 Rhee et al. (1998) and Yang et al. (1998) developed a PPG ring 




patient’s arterial blood volume waveforms and blood oxygen saturation, with data 
wirelessly transmitted to a computer by an embedded RF transmitter.  LEDs with two 
different wavelengths, red and near infrared, as well as a photodiode were imbedded 
in the ring, where the technology of pulse oximetry was implemented for blood 
oxygen saturation monitoring.  Signals were received and analyzed by a home 
computer.   Rhee et al. (2001) and Asada et al. (2003) proposed several solutions to 
reduce noise due to an ambient light source and motion artifacts.  A double ring 
design was developed to lower the influence of external force, acceleration and 
ambient light to minimize artifacts.  In this design, the optical sensor unit was 
separated from the rest of the ring body that was much heavier.  This was achieved by 
having two rings mechanically decoupled to each other with only a thin flexible cable 
connects the two rings.  The inner ring holds the sensors units alone while the outer 
ring contains the other parts.  This design alleviates the influence of external forces 
applied to the ring, and shields the sensor unit from ambient lighting (Rhee et al. 
2001).  Other artifact reduction solutions were also investigated.  A transmittal PPG 
configuration was chosen since it is less susceptible to disturbance than reflective 
PPG configurations (Asada et al. 2003).  An accelerometer was used as a motion 
reference sensor to recover signals corrupted by motion artifacts (Asada et al. 2004).  
A reflective photo diode was proposed to be used as a motion reference sensor for 
canceling the disturbance and noise, since it is susceptive to disturbances (Asada et al. 
2003).  In addition, local pressure was proposed to be applied to increase the 




al. 2003), since applying a certain magnitude of pressure on the skin surface will help 
attaining stable PPG signals (Rhee et al. 2001).  
Another key issue for developing the compact, wearable ring sensor is to 
reduce the power consumption, since the determinant factor of the dimension and 
weight of the ring sensor is those of a battery cell to be used (Yang et al. 1998).   
Rhee’s ring sensor used a CPU to exploit digital control and transmission techniques 
in order to perform reliable and flexible operations with reduced power consumption 
(Rhee et al. 2001).  Optimal internal clock frequency was obtained to minimize power 
consumption by analyzing the total power consumption in relation to characteristics 
of individual components, sampling rate, and CPU clock speed (Rhee et al. 2001). 
Spigulis et al. (a, b) developed a portable PPG prototype device to detect the 
blood volume pulsations of micro-vessels in the skin, which contains information of 
metabolism and thermoregulation.  It consists of an optical contact probe with a 
reflection type PPG sensor, bio-signal amplifying / filtering circuit and a lap-top 
computer with developed software.  Diodes are closely mounted on a soft plastic 
pillow and fixed onto the measurement site by means of a sticky band.  With adjusted 
length, the band can measure PPG at the finger tip, or from different locations of the 
body, e.g., forehead, neck, forearm, and knee (Spigulis et al. a).  The device had 
undergone several tests and clinical results were obtained by analyzing the signal 
shapes detected from different sites. 
Branche et al. (2004) developed wearable reflective pulse oximeters 
incorporated in the helmet for military applications.  Commercially available 




double-sides disposable tape.  In Branche’s study, alternative sensor attachment 
techniques were investigated by utilizing the existing helmet suspension liner, 
adjustable harness, and chin strap to secure the sensor to the skin.  Simultaneous 
measurements acquired from the forehead, chin, jaw and nape areas indicated that the 
forehead region provides the best location for obtaining reproducible readings.  
Preliminary results confirmed that it is possible to achieve reproducible data from a 
helmet-mounted reflectance pulse oximeter sensor without the need to use adhesive 
tape to secure the sensor on the skin or readjustment of the helmet straps between 
successive measurements.   
Pulse oximeters are accurate in the range of oxygen saturation of 70 to 100% 
(± 2%), but less accurate under 70% as there are no control oxygen saturation values 
to compare the data (Fearnley 1995, Hill and Stoneham 2000).  Pulse oximetry is less 
effective in critically ill patients because tissue perfusion may be too poor for the 
pulsatile signal to be detected (Hill and Stoneham 2000).   Pulse oximeter readings 
are not accurate in some situations including when there is a reduction in peripheral 
pulsatile blood flow produced by peripheral vasoconstriction or peripheral vascular 
disease, and in the situation of venous congestion.  The signal can also be interfered 
by ambient lights, vascular dyes, skin pigmentation, nail varnish, and motions that 
cause transient change in the distance between the LEDs and the detector (Fearnley 
1995, Welch et al. 1990, Hill and Stoneham 2000).   Modern technologies have 
utilized several methods to reduce the effects of interference.  These include time 
division multiplexing and quadrature division multiplexing.  Time division 




many times per second, helps to eliminate background noise.  In quadrature division 
multiplexing, the red and infrared signals are separated in phase rather than time and 
then recombined in phase later.  Motion artifact or electromagnetic interference can 
be eliminated since it will not be in the same phase of the two LED signals once they 
are combined (Hill and Stoneham 2000).   
In summary, research have been conducted on the development of ambulatory 
PPG monitors and pulse oximeters, focusing on device miniaturization, power 
consumption reduction and noise minimization.  The clinical usefulness of the 
continuous ambulatory monitors still requires evaluation. 
 
1.5   Acoustic Monitor for Cardiac Sounds 
Heart acoustic emissions consist of short, impulse-like events, termed “heart 
sounds”.  These are produced at transitions between the different hemodynamic 
phases of the cardiac cycle, and other acoustic emissions that are generally of longer 
duration and may occur within any phase of the cardiac cycle, termed “murmurs”. 
Four heart sounds have been identified, referred to as first (S1), second (S2), 
third (S3) and fourth (S4) heart sound.  The heart sounds are multi-component, non-
stationary signals (El-Asir and Mayyas 2004, Wood and Barry 1995, Xu et al. 2001).  
Most cardiac sounds have spectra that lie in the range of 1 to 1000 Hz (Selig 1993), 
but certain murmurs have frequencies up to 1500 Hz (Akay et al. 1992).   
Abnormalities in S1 and S2 and the presence of S3 and S4 and certain murmurs can 




Cardiac auscultation has been a fundamental diagnostic measure in medical 
practice, and remains the most cost-effective method of initial cardiovascular health 
evaluation.  Efforts to develop a wearable, wireless stethoscope are still in progress.   
Scanlon (1998) developed wired acoustic sensors that could be used in a 
wearable acoustic monitoring system of soldier’s cardiac, respiratory and voice 
sounds, and footfalls.  This could enable the monitoring of soldier’s physiological 
status (e.g., injury, hypothermia, dehydration) by field medical personnel, and of 
manpower availability by military commanders.  The sensors consisted of 1 to 1.6 
inch diameter flexural piezoceramics in an aqueous gel coupling layer, which 
provided acoustic impedance matching with human tissue, and impedance mismatch 
with air for ambient noise reduction.  The sensors were mounted using straps, 
harnesses and a helmet headband at the torso, neck and head.  However, the 
separation of cardiac sounds and noise (in particular, footfalls) based on short time 
Fourier transform analysis and the filtering used was not satisfactory, even for heart 
beat measurement.  Individual’s tolerance to sensor mounting hardware was also 
identified an area for improvement, highlighting the need for miniaturized, wireless 
sensors.  Wireless heart sound monitoring systems have also been proposed for real-
time continuous monitoring of heart failure patients by home-based telecare 
(Mendoza and Tran 2002), or for controlling the exercise levels of rehabilitation 
patients (Kim and Jong 2001).   Such systems enable remote health care personnel to 
be informed of a dangerous status by wireless data transmission.  
Asada et al. (2001) described concepts to develop passive, batteryless MEMS-




wearable, wireless stethoscope/telephone system.  The sensors would be adhesively 
skin-attached for continuous cardiac and respiratory sounds monitoring and 
behavioural monitoring (e.g., eating, drinking speaking, coughing, walking).  The 
system would inductively transmit vital sounds (e.g., pulse rate, heart rate variability, 
respiration rate) and voice recorded at the neck, chest, and cheeks wirelessly to a 
cellular phone.  The technical challenges identified included the reduction of noise 
created by body motion, for which a sensor array was considered, loss of acoustic 
signal due to possible de-adhesion between the sensor and skin, and possible skin 
irritation.  Cho and Asada (2002) developed these concepts further for respiratory 
sound monitoring of asthma patients and pulmonary disease patients.  The feasibility 
of the proposed inductive acoustic data transmission concept was computationally 
assessed. It was concluded that limitations in mutual inductance would limit the use 
of such a system to short range monitoring, but these limitations were not quantified. 
The application of heart sound measurement to CVD monitoring in prototype 
ambulatory devices has been hampered in part by the difficulty of reducing 
environmental noise and other unwanted sound such as respiration sound and speech, 
the frequencies of which largely overlap heart sound signals.  Noise reduction 
methods include filtering, digital signal processing techniques, and the use of multiple 
noise reference sensors (Wang and Wang 2003).  Although both environmental and 
lung sounds can be separated from cardiac sounds using signal processing techniques 





Substantial efforts have been invested in cardiac sound measurement and 
analysis.  However, challenges of noise reduction (e.g., environmental, respiratory, 
vocal) in ambulatory monitoring devices, and improving the understanding of heart 
sound genesis and propagation for pathology diagnosis, remain.  The majority of 
researchers have focused on the identification and extraction of the morphological 
characteristics of the heart sounds, rather than on the application of heart sound 
measurement to the diagnosis of cardiac diseases.  Despite advances in digital signal 
processing, wireless data transmission and sensor technologies, the measurement of 
cardiac sounds in current commercially-available health monitoring devices remains 
confined to heart rate monitoring (Eveloy et al. 2005).  
 
1.6   Impedance Cardiograph 
Impedance cardiography (ZCG, or ICG)29 records impedance changes 
occurring in synchrony with respiration and ejection of blood into the aorta by 
emitting and recording a high-frequency alternating current along the thorax.  Heart 
rate (HR) and systolic time intervals can be directly determined from the signals.  
Stroke volume (SV) and cardiac output (CO) can be estimated with proper algorithms 
(Nakonezny et al. 2001).  
There are two types of measuring systems.  The first system uses four band 
electrodes: two around the neck, the third one corresponding to the apex of the heart, 
and the fourth one further in the caudal direction.  The second system uses eight 
electrodes: four around the neck and the others at the lower thorax (Grimnes and 
                                                 
29 Impedance cardiography is a safe and noninvasive technique suitable for assessing cardiac function by measuring impedance 




Martinsen 2000).  The second system was found to have a better signal-to-noise ratio 
(Grimnes and Martinsen 2000). 
The amplitude of the impedance change is about 0.5% of the basic impedance 
value.  The signal must be corrected for the variations due to respiration (Grimnes 
and Martinsen 2000).  The technique has the advantage of being simple, cost 
effective, and noninvasive (Morucci et al. 1996).  For impedance cardiography, it is 
multiple parts rather than a single structure within the thoracic cavity that is 
responsible for the impedance change.  The relative contributions do not seem to be 
constant on an interindividual basis, and these contributions vary in an unpredictable 
way in pathological conditions (Morucci et al. 1996).  A strong theory is lacking for 
impedance cardiography and it is still open for research (Morucci et al. 1996). 
Currently most studies of impedance cardiography are conducted for resting 
patients in the laboratory or clinical environment (Sherwood et al. 1998).  
Ambulatory impedance cardiography has been commercialized by MindWare.  
Research of ambulatory impedance cardiography monitoring devices was also 
conducted by several groups.  Cybulski et al. (1995) constructed an ambulatory 
monitor and record the signal on a 20-MB PCMCIA (Personal Computer Memory 
Card International Association cards) Flash Memory Card.  Recorded signal allows 
off-line data analysis and beat-to-beat evaluation of cardiac output, stroke volume, 
ejection time, preejection period, and heart rate. Ambulatory impedance cardiography 





In Cybulski’s monitor, the system has been checked in 80 healthy subjects in 
ambulatory conditions (Cybulski et al. 1995, 1997, 2000).  Hemodynamic signals 
were recorded using the ambulatory monitor together with simultaneous collection of 
ECG signals to demonstrate the hemodynamic efficiency of pacing in arrhythmic 
patients (Cybulski et al. 1997).  Using the ambulatory monitor hemodynamic 
variability was also studied for patients with atrial fibrillation, and the results showed 
that these patients had increased variability of stroke volume than that of healthy 
adults (Cybulski et al. 1999).  
Artifacts can be caused by motion, respiration and speaking.  In Cybulski’s 
ambulatory impedance cardiography, the percentage of properly recognized heart 
cycles with respect to the estimated parameters varied from 20 to 80% during the day 
and from 75 to 90% at night.  Speaking and vigorous movements will corrupt the 
signal and markedly lower the useful signal percentage.  Raza et al. (1989) developed 
a digital high pass filter to eliminate respiration artifacts from impedance 
cardiographic signal.  The filter automatically selects the cutoff frequency (CF) as a 
function of the heart rate.  Other studies on reducing artifact of impedance 
cardiograph are limited in processing received signals, without considering 
eliminating the influence of artifact sources.  
For bioimpedance, multiple electrodes have to be attached to the neck and 
upper body, raising again the problem of patient tolerance for long term continuous 
monitoring.  Future studies on improving signal stability under real ambulatory 






1.7   Other Monitors 
Other monitors under development include the Doppler Necklace proposed by 
Awad and Asada (Awad and Asada 1999, Asada and Awad 1999), using an 
accelerometer to record Arterio-Oscillo-Gram in Pouladian and Golpayegani et al.’s 
study (2003, 2005), and using accelerometers to monitor motility and postures by 
Grossman.  
Awad and Asada (1999) presented a conceptual Doppler Necklace utilizing 
the Doppler ultrasound technology30 to measure blood velocity.  Piezoelectric 
ultrasound sensors were proposed to be mounted on the neck to continuously monitor 
blood flow in the common carotid artery (Awad and Asada 1999, Asada and Awad 
1999).  The centerline velocity in that artery contains information of cardiac 
performance, diastolic cerebral flow, and the time rate of change of the pressure pulse 
waveform.  An array of equally spaced transducers was designed to provide wide 
sector coverage in the neck, to resolve the problem of vessel location uncertainty.  
The transducers were designed to be alternately driven and the one yielding highest 
velocity is considered to correctly target the centerline of the vessel, thus is kept in 
emitting mode.  Adjacent transducers can also be excited according to the need.  Thus 
a reliable measurement is possible despite motion and location uncertainty of the 
target vessel.  The signal is transmitted to a computer and the blood velocity can be 
analyzed continuously.  
                                                 
30 Doppler ultrasound technology has been used within clinical environment to measure blood velocity and require a special 
operator since the technique is complicated.  When using this technique, a sinusoidal voltage excites a piezoelectric crystal to 
create an ultrasound beam.  The beam intercepts the target vessel and the backscattered ultrasound, having a frequency shift (the 





In Pouladian and Golpayegani’s research (2003, 2005), an accelerometer was 
noninvasively over brachial artery to measure the vibrations and oscillations of the 
arteries.  The measured acceleration signal was named arterio-oscillo-gram (AOG). 
Mean of normalized spectrual samples between 30 and 250 Hz was calculated and 
defined as a feature.  It was found that the more coronary occlusions (more severity of 
atherosclerosis), the larger the feature.  This method, claimed by Pouladian, has the 
potential of being a screening tool for diagnosing atherosclerosis.  The test results 
showed that this method can detect CAD (coronary artery disease) with 70% 
accuracy, and non-CAD with 90% accuracy.    
Grossman proposed to use accelerometers in an ambulatory multiple 
parameter monitoring system (LifeShirt) to precisely quantify daily physical activities 
and energy expenditure.  Accelerometers have been widely used to monitor human 
posture and movement parameters, including step rate, step rate variability, rise time, 
postural orientation during sitting and standing, postural sway during quiet standing 
and the energy expenditure in each movement (Mathie et al. 2004).  However, little 
progress is made to develop tools to help directly identify specific situations and 
activities that trigger dangerous cardiac events (Grossman).  Since many diseases, 
including coronary artery disease, are typically associated with aberrant physical 
activity levels, distinctive patterns of activity and energy expenditure might be seen 
for certain disorders after applying ambulatory physical activity monitors, and may 





1.8   Noninvasive Multiple Sensors Monitoring Systems  
VivoMetrics developed a sleeveless vest with embedded sensors (inductive 
plethysmography sensors, ECG electrodes, and a accelerometer) and optional 
peripheral diagnostic devices (blood pressure monitor, pulse oximeter, etc.) that can 
monitor a wide range of physiological parameters including ECG, respiration, 
physical activity and posture, blood pressure, blood oxygen saturation, skin 
temperature etc. (VivoMetrics).  Data is recorded in a PDA worn on the patients’ belt 
or put into a pocket.  The screen of the device allows patients’ subjective input of 
symptoms and activities synchronized to the recorded signals.  A rechargeable battery 
and an exchangeable flash memory card can provide up to 24 hours continuous 
recording.  Data is uploaded to a personal computer, sent to the Data Center via 
internet, and then reviewed and analyzed in the Data Center including calibration, 
artifact screening, parameter extraction and trends.  The system has been used in 
more than 1000 hospitals worldwide.  The system need to be further validated to 
assess the efficiency of the automatic artifact screening algorithms and the accuracy 
of certain parameters measured during postural changes.  In addition, the usefulness 
of several extracted parameters in ambulatory monitoring has not been demonstrated. 
A monitoring vest was developed by Sundaresan Jayaraman’s team at Georgia 
Institute of Technology and is now sold by the company Sensatex for detecting bullet 
wounds (Georgia Tech, Sastry 2004).  The Georgia Tech Wearable Motherboard 
(Smart Shirt) provides a framework for the incorporation of sensing, monitoring and 
information processing devices.  Plastic optical fibres are woven in the shirt and 




of bullet detection.  Pulses of light are detected constantly by the diode with any light 
interruption indicating the exact location of the bullet’s entry (Sastry 2004).  Sensors 
have been plugged into the Smart Shirt and attached to any part of the subject being 
monitored.  Flexible data buses integrated in the vest transmit data to recorders 
(Georgia Tech, Sastry 2004).  
A wearable human-computer interaction technique (MIThril) is under 
development in the MIT Media lab.  The hardware platform combines body-worn 
computation, sensing and networking in a clothing integrated design.  The software 
combines user interface elements and machine learning tools (MIT Media Lab). 
Different from the above wearable network systems that have metallic cables 
woven into the garment and bulky sensor size, a cable-free wearable sensor system 
was proposed by Wade and Asada (2004).  The network infrastructure is based on the 
use of conductive fabrics as the electrical transmission medium, so that metallic 
cables can be eliminated.  Two conductive sheets serve as the medium for power and 
data transmission instead of cables in traditional designs (Wade and Asada 2004).  
Building a monitoring shirt as a real “personal computer” can allow wider 
sensor location choices.   Noninvasive monitoring systems integrated with multiple 
sensors are under development and have become a hot topic.  However the fully 
functioned device with sensors and recorders is quite bulky and device 





1.9   Discussion and Conclusions 
There is a need for continuous cardiovascular monitoring to enable the long-
term, real time detection of critical signs, risk factors, effects of therapy, and 
symptoms precursor to sudden death.  Non-invasive ambulatory cardiovascular 
monitors are receiving more attention as a means of addressing this need and 
supplementing traditional medical and clinical care.  
The monitoring of many CVDs is complex as generally there is no single 
parameter that is sufficient to assess CV health, except for very specific CVDs (e.g., 
arrhythmia).  Various kinds of noninvasive CVD monitors exist with different 
technology maturity levels.  Ambulatory ECG and blood pressure monitors have been 
used in clinical practice and has improved health surveillance.  While the value of 
ambulatory ECG monitoring is undisputed, particularly in the context of life 
threatening arrhythmia, the usefulness of ambulatory BP monitors has not been fully 
established.  Ambulatory monitors of parameters except ECG and blood pressure are 
in the early development stage, including pulse oximeters, heart sound and 
bioimpedance monitors.  For these parameters, clinical usefulness of the continuous 
ambulatory monitors need to be further evaluated.  The majority of the efforts are 
devoted to the development of new devices, with few studies focused on the 
evaluation of their medical value.  This indicates that the exploration stage is not 
complete for noninvasive ambulatory cardiovascular monitors.     
Current CV monitoring approaches focus on the detection of specific diseases 
and are weak on prognostic value.   Commercialized Holters and blood pressure 




period, existing monitors are focusing on specific disease detection or certain 
parameter recording rather than year-long observation and trend analysis.  Future 
health monitors may extend their ability to either detect CVD by monitoring 
symptoms, or predict CVD by monitoring risk factors.  Longer term cardiovascular 
monitoring is less explored and it is not yet known whether it can provide valuable 
information compared to occasional examination by a doctor.  For extended 
monitoring period, low power consumption, device miniaturization, and data storage 
or transmission capacity become critical. 
Ambulatory cardiac monitors should provide stable signals during the 
patient’s daily activities.  Resistance to motion artifact remains a significant challenge 
for all types of ambulatory monitors.  Efforts are ongoing to eliminate artifacts by 
improving hardware design and applying signal processing algorithms. 
The recorder size of the existing ambulatory ECG monitors and blood 
pressure monitors is quite bulky and heavy.  In addition, for Holter ECG monitors, 
cumbersome wires and patches on the chest make it uncomfortable to wear in long 
term usage.  In general, inconvenience or complexity, lack of comfort in wearing the 
monitor, and high cost limit the wide acceptance of these devices.   
Various studies have been devoted to the development of ring, watch, band, or 
garment based wearable monitors, to improve the patience tolerance.  However, 
whether the commercial ambulatory monitors can provide accurate information needs 
to be scrutinized.  For ambulatory blood pressure monitors, measurements obtained 
from a finger or wrist are not equivalent to those obtained using traditional upper arm 




finger BP monitors will require additional data interpretation and correlations with 
upper arm data. 
Although a number of continuous health monitoring devices are being 
developed, currently-available solutions do not fully address the needs of cardiac 
monitoring.  The majority of studies have focused on development of the ambulatory 
devices, rather than exploring their clinical usefulness.  Electrocardiographic (ECG) 
and blood pressure monitors (BP) are generally considered the most mature non-
invasive ambulatory cardiovascular monitoring technologies.  For other monitors, 
convincing evidence of the medical value is still lacking.   
Further improvements in miniaturization and artifact reduction will remain 
critical to improve the wearability, patient acceptance and medical value of existing 
ambulatory cardiovascular monitors.  These attributes are limited by factors including 
mechanical design constraints associated with the sensing mechanisms, power 
consumption, data storage, the range of ambulatory conditions encountered, signal 
processing and computational limitations, and cost.  With advances in these areas, it 
is anticipated that cardiac monitoring devices will further contribute to an improved 









Chapter 2: Reduction of ECG Motion Artifacts 
 
2.1   Motivation / Problem Statement 
The performance of current electrocardiogram (ECG) monitors can be 
significantly degraded by motion artifacts, which can cause misdiagnoses, 
inappropriate treatment decisions, and trigger false alarms (Wiese et al. 2005, Friesen 
et al. 1990, Smith 1984, Burbank and Webster 1978, Tam and Webster 1977).   
These artifacts31 arise from physiological sources, namely potentials generated 
in the epidermis by skin stretching due to patient motion and electromyographic 
signals32, and nonphysiological sources, namely external electromagnetic signals such 
as the 60 Hz pickup33, offset potentials produced by the electrode34, signals produced 
by the interaction of body fluids and the electrode gel (resulting in lack of electrolytic 
gel), imperfect lead wire and cable connections (Smith 1984, Wiese et al. 2005).  
Various types of artifacts have been eliminated by modern design.  Interference due 
to power lines has been greatly reduced by the development of the driven-right-leg 
circuit (Webster 1984).  EMG signals can be electronically filtered from the ECG 
signal (Smith 1984).  Artifact caused by the electrode has been eliminated by the 
development of the floating silver/silver chloride electrode (Smith 1984, Webster 
1984).   
                                                 
31 Signal distortion. 
32 Electrical activity in muscles. 
33 The 60 Hz pickup results from the radiation of energy from 60 Hz power lines.  




In modern ECG monitoring, especially in ambulatory and stress 
electrocardiography, motion artifacts35 due to skin stretching are the main source of 
noise in ambulatory and stress electrocardiography utilizing traditional Ag/AgCl 
electrodes (Wiese et al. 2005, Smith 1984, Burbank and Webster 1978, Tam and 
Webster 1977, Webster 1998, Odman and Oberg 1982, Webster 1984) even with the 
use of sophisticated algorithmic filtering (Wiese et al. 2005).  Skin stretching causes 
mechanical disturbances of the distribution of charges at the electrode-electrolyte 
interface, which induces a temporary change in the half-cell potential (Webster 1998).  
Such artifacts can produce signals that resemble the actual P, QRS, and T time 
waveforms of the ECG, are of similar frequency, and have a comparable or higher 
amplitude (Smith 1984, Hamilton and Curley 1997, Tong 2002).  Figure 2 shows the 
ECG signal without artifact and motion artifact corrupted ECG signal.   
 
                                                 





Figure 2. (a) ECG signal without artifact; (b) ECG signal with notion artifact 
 
2.2   Previous Studies  
The interpretation of the clinical ECG relies on physician or computerized 
analysis to recognize artifacts (Chia et al. 1991, Kadish 2001).  Approaches 
previously investigated to reduce motion artifacts include skin abrasion at the 
electrode site (Tam and Webster 1977, Burbank and Webster 1978), and adaptive 
filtering techniques that utilize as a reference signal either electrode motion measured 
using single or dual axis accelerometers (Raya and Sison 2002, Tong et al. 2002, 
Tong 2005) or a two-axis magnetoresistive sensor (Tong et al. 2002), skin stretch 
related signals measured using a strain gauge (Hamilton and Curley 1997, Hamilton 
et al. 2000a, 2000b, 1999), or electrode/skin impedance measurements (Hamilton et 
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(Luo and Tompkins 1995).  Such efforts are still in progress and artifact reduction 
remains a challenge for ambulatory ECG monitoring.  
2.2.1   Skin Stretch - the Main Source of ECG Motion Artifact 
Tam and Webster’s (1977) research indicated that the change in skin potential 
is the major source of motion artifact and proposed the method of skin abrasion to 
minimize this artifact.  Odman and Oberg (1982) studied movement-induced 
potentials in various electrode configurations and concluded that potentials generated 
by skin deformation beneath the electrode dominate the disturbance pattern in ECG 
recording.  The potential created due to gel movements at the electrode disc, or 
caused by gel movement relative to the skin are not the main reason of motion 
artifact. The potentials do not depend on impedance variations.  Webster (1984) 
reviewed various types of artifacts in biopotential recording, the sources and the 
means for minimizing them. He concluded that the major motion artifact in ECG 
recording arises from the skin and not the electrode.  Burbank and Webster (1978) 
studied the skin stretch-artifact properties and quantified the skin stretch induced 
artifact in biopotential recording. The amount of artifact can reach up to 17 mV when 
the skin strain is 6%.  
Skin can be considered as a current generator. It actively generates a potential 
difference between the inside and the outside of the skin. Consequently, the outside of 
the skin is more negative than the inside. Stretching the skin causes a reduction in the 
magnitude of this skin potential. Variation of this potential is a source of artifact in 
electrocardiography. There is no widely accepted interpretation of the variation with 




outside of the barrier layer is typically 30 mV. When the skin stretches, the skin 
potential decreases to about 25 mV and this 5 mV change is the observed motion 
artifact (Webster 1984). 
Figure 3 shows that the skin consists of three layers: the epidermis, the dermis 
and the subcutaneous layer. The epidermis is made up of another three layers: stratum 
corneum, stratum granulosum and the stratum germinativum.  The surface layer, 
stratum corneum, is a layer consist of dead cells, with a thickness between 0.02 mm 
and 0.7 mm (Tam and Webster 1977). New cells form within the germinating layer 
(stratum germinativum) and over about 30 days move outward through the barrier 
layer (stratum granulosum) to the stratum corneum on the surface, and then fall of 
(Webster 1984).  
 





Thakor and Webster (1978) and de Talhouet and Webster (1996) 
approximated the skin layers as an equivalent circuit model consisting of resistors and 
a current supply (Figure 4). Thakor and Webster (1978) hypothesized that the skin 
potential arises from a constant current source called ‘injury current’ flowing through 
the extracellular resistance. In this current model of epidermis, the injury current, 
caused by difference of metabolic activity between the dead cells of the stratum 
corneum and the viable cells of the inner layers of the skin, flows through the 
extracellular channels which cause the negative dc voltage drop from the inside to the 
outside of the skin. de Talhouet and Webster (1996) validated Thakor’s model 
through experiments, and quantified the change in epidermal skin impedance and skin 
potential measured using an Ag/AgCl electrode with the stretched force that was 
imposed with hung weights. It was found that the skin potential change and skin 
impedance change increase with weight in a logarithmic relation (de Talhouet and 
Webster (1996). The decrease of impedance of the transitional region shunted by the 
current was attributed to the extracellular channels increase in diameter when 





Figure 4. Thakor and Webster‘s (1978) injury current model of epidermis 
 
2.2.2   Reduce Motion Artifact by Skin Abrasion and Puncturing 
Tam and Webster (1977) showed that about 20 strokes of fine sandpaper 
reduce the skin potential artifact from 5 mV to a negligible value.  The fine sandpaper 
strokes scratch through the barrier layer and short circuit the skin potential.  However, 
this method can cause skin irritation and a mild gel must be used to avoid irritation. In 
addition, they found that the skin regrows in 24 hours and artifact returns.   
Burbank and Webster (1978) devised a needle-puncture method to reduce 
artifact from 5-10 mV to less than 0.2 mV through 10 0.5 – mm skin punctures. A 
blood lancet protruding 0.5 mm from an X-Acto knife blade chuck punctured the skin 
20 times. The results showed that motion artifact can be minimized by this method, 










These approaches will cause patient discomfort, prolong procedure 
preparation time or even infection.  Furthermore, they do not provide an effective 
solution to long term monitoring.   
2.2.3   Reduce Motion Artifact by Adaptive Filtering 
Adaptive filtering has been used in many biomedical applications. It has been 
applied in fetal ECG recording, cancellation of cardiogenic interference from an 
impedance plethysmographic signal, 60 Hz powerline interference cancellation, 
muscle noise reduction, baseline wander reduction in ECG, and ECG motion artifact 
reduction (Thakor and Zhu 1991).  Other proposed adaptive algorithms to reduce 
ECG motion artifact include using adaptive neural networks (Xue et al. 1992) and 
fuzzy-rule-based adaptive nonlinear filters (Kiryu et al. 1994) to track the changing 
characteristics of the noise in an ECG and adjust the filters to reduce as much the 
motion artifact as they can.   
Figure 5 shows the basic structure of applying adaptive filtering in ECG 
motion artifact removal. Noise is subtracted from a received signal in an adaptive 
manner. There are two signal inputs. A primary input contains the ECG signal 
corrupted by additive and uncorrelated noise. An auxiliary input derived from a 
second sensor located in the noise field supplies signal that highly correlated with the 
unknown noise but uncorrelated with pure ECG signal. The adaptive filter estimated 
noise in an adaptive manner and eliminate the additive noise through the noisy ECG 





Figure 5. Adaptive filter structure 
 
Tong et al. (2002, 2005) monitored the electrode acceleration by attaching a 3-
D accelerometer and a 2-axis anisotrophic magnetoresistive sensor respectively on the 
exposed surface of an electrode (Figure 6). The electrode acceleration signal was 
measured simultaneously with ECG signal and used to estimate motion artifact with 
adaptive filtering. Motion artifact was induced by pushing on the electrode, pushing 
on the skin around the electrode and pulling on the electrode lead wire. The results 
indicated that adaptive filter with a reference motion sensor can significantly educe 
motion artifact. The improvement ranges from 24% to 91% depending on the motion 
type and the reference sensor type.  However, imposed electrode motion may not 
fully replicate in daily activities, and skin stretch caused by daily activities were not 















Figure 6. Measurement of electrode motion using an accelerometer (Tong 2000)  
 
Raya and Sison (2002) attached on the subject’s back a 1-D and 2-D 
accelerometer respectively to measure body acceleration as the reference signal to 
reduce ECG motion artifact.  The subject was walking and running during the stress 
ECG test. The results showed that motion artifact in stress ECG was reduced 
effectively by using a single-axis acceleration signal as the noise reference. A single 
noise reference gave a better result than dual-axis noise reference regardless of the 
adaptive filtering algorithm applied. Recursive least square (RLS) algorithm gave a 
superior performance than Lease Mean Square (LMS) algorithm. Since RLS 
converges faster than LMS, it can improve the signal to noise ratio in a rapidly 
varying environment compared with LMS. The noise reduction results were not 




Hamilton et al. (Hamilton and Curley 1997, Hamilton et al. 2000a, 2000b, 
1999) mounted a strain gauge and an optical bend sensor on the exposed surface of an 
electrode respectively to measure electrode deformation as the noise reference. 
Artifact was generated by pulling on the skin and pushing on the electrode. The result 
indicated that adaptive filter can effectively reduce motion artifact. Different adaptive 
filtering algorithms have different noise reduction performance. Filter order larger 
than four don’t contribute greatly to further noise reduction. The average noise 
reduction in false detection for the controlled conditions (pulling on the skin and 
pushing on the electrode) is 72.6%.  The residual artifact may result from nonlinear 
behavior of the foam-sensor arrangement used to indicate skin stretch or nonlinear 
relationship between the skin stretch and the artifact amplitude. In addition, during 
ambulatory monitoring significant artifact may be generated by skin stretch that does 
not deform the electrode in ways that are well detected by the strain gauge or the 
optical bending sensor. Imposed electrode bending may not fully replicate in daily 
activities and skin stretch caused by daily activities was not taken into account.   
Devlin et al. (1984) used electrode / skin impedance variations to estimate and 
reduce the relative amount of electrode motion artifact in the ECG signal, so as to 
reduce false positive alarms triggered by motion artifact.  The time-varying 
impedance of the electrode / skin interface was monitored by passing a small AC 
current through the ECG electrode and measuring the resultant potential difference 
across the electrodes. Artifacts were introduced by scratching and tugging on the 
electrodes, and abrupt physical movements. The results showed that 82% of the false 




the torso impedance will introduce the possibility of impedance artifact generated by 
breathing or heart pumping.  Hamilton et al. (2000b) further investigated using skin / 
electrode impedance to adaptively filter motion artifact from ECG signals.  Low 
frequency impedance was measured in Hamilton’s (2000b) study, different from the 
20 kHz impedance used by Devlin et al. (1984), since low frequency impedance 
should be more sensitive to changes in skin impedance and less sensitive to changes 
in torso impedance. The results showed that artifact reduction decreased with 
increasing impedance frequency. Artifact reduction improved with the order of the 
filter, but the improvement was not significant for filter orders larger than four.  
However, it was unclear that how the movement-induced artifact is correlated with  
Luo and Tompkins (1995) obtained voltage difference from two adjacent 
electrodes (5 mm apart) as a noise reference signal. The artifacts were induced by 
raising the right lower arm from a relaxed position until the lower arm makes contact 
with the brachium. The results showed that RLS algorithm converges faster than the 
LMS algorithm and performs satisfactorily in reducing ever rapidly varying brachial 
artifact. The method also significantly improved the low frequency baseline shift. 
Noise reduction results were not quantified in the study. Local skin stretch caused 
artifact was not taken into account in this method.  
These studies demonstrated that adaptive filtering is an effective method to 
reduce motion artifact in ambulatory ECG, stress test and long term ECG monitoring.  
However, the estimated noise reduction could vary significantly depending upon the 
source of skin stretch, namely applied electrode motion or deformation, or body 




adaptive filtering.  No single combination of reference variable, sensor, and filtering 
algorithm could reduce the noise in a reproducible/consistent manner for all electrode 
or body motions studied.  The results suggests that an important contributing factor 
for the lack of consistency in the estimated noise reduction is that the references 
variables used, namely electrode acceleration, electrode strain etc., were not 
adequately correlated with the induced motion artifact.  In addition, the induced 
motion artifact in previous studies does not take into account skin stretch caused by 
daily activities.  As a result, motion artifact generated by skin stretch that does not 
deform the electrode or is not caused by electrode motion etc. will not be detected by 
previously used sensors as an auxiliary input to adaptive filtering.   
 
2.3   Research Objective 
The research objective is to reduce skin stretch induced artifacts in the 
measured ECG.  To achieve this, a method and prototype was developed to directly 
measure skin stretch simultaneously with ECG.  This process involves the integration 
of an optical technique in an ECG electrode.  Using the measured skin stretch data, 
skin stretch induced artifacts are reduced in the measured ECG with adaptive filtering 
technique.   
Different from previous studies, in this work skin stretch is directly measured 
as an auxiliary input in adaptive filtering.  Figure 7 shows the block diagram of the 
cause and effect relationship between variables and motion artifact in previous 






Figure 7. Block diagram of the cause and effect relationship between variables and 
motion artifact 
 
2.4   Research Methodology 
Adaptive filtering method is used to transform the optical sensor output into 
the motion artifact induced in the ECG leads.  An estimate of the artifact is then 
subtracted from the corrupted signal resulting in an electronic signal with reduced 
motion artifacts.  Figure 8 shows the electrode/ sensor system and adaptive filter 



























Figure 8. Electrode/ sensor system and adaptive filter structure to reduce ECG motion 
artifact 
 
The general research methodology includes the following procedures: 
1) Incorporate a noninvasive optical technique to measure skin strain 
in the ECG electrode package 
2) Calibrate the optical strain sensor in-vitro and in-vivo in terms of 
sensitivity and measurement range 
3) Record ECG with induced artifacts and skin strain simultaneously, 
and reduce the artifacts offline with adaptive filtering   
4) Quantify artifact reduction performance of this sensor system and 
method    
5) Test performance of this sensor system and method under various 
types of motions that mimic everyday activities 



















Chapter 3: Optical Sensor Calibration and Prototyping 
 
3.1   Integration of an Optical Sensor into an ECG Electrode 
Figure 9 illustrates one embodiment of a skin-mounted physiological 
recording electrode assembly, with the isometric view on the left and exploded 
isometric view on the right.  The electrode assembly has a foam pad with the font 
surface contacting the skin and a rear surface connecting to the lead wires. The front 
surface of the foam pad has a central recessed region filled with liquid gel or solid gel 
to establish electrical contact between the electrode and the skin.  The Ag / AgCl 
electrode resides in the central recess of the foam pad with a connector end protruding 
from the foam pad.  A clip grips the connector end of the electrode and connects a 
lead wire to recording and processing equipments.  An optical sensor and a light 
emitting diode (LED) are embedded in the foam pad near the electrode site, with a 
recessed region underneath the sensor and the LED (Liu and Pecht 2006, Pecht and 
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Figure 9. Isometric view (left) and exploded isometric view (right) of an optical 
sensor integrated electrode 
 
Optical components integrated in an electrode are illustrated in Figure 10.    
LED illuminates the skin surface, revealing surface details (slight imperfections) that 
the optical sensor can use to track movement.  The optical sensor consists of a CMOS 
image sensor and a digital signal processor to determine the direction and amount of 
the relative movement between the sensor and the imaging area beneath it.  Lenses 















Figure 10.  Optical components integrated in an electrode 
 
Optical sensors used in this study are based on optical navigation technology.  
Optical navigation has also been used in target tracking in military applications, 
optical mouse, and motion compensation in hand-held video cameras, which is 
critical to the practical utility. 
Figure 11 illustrates the illuminated skin surface area underneath the CMOS 
image sensor.  The CMOS sensor is an image array ranges from 16 × 16 pixels to 30 
× 30 pixels.  Let L be the distance between the fixed edge and the imaging area.  
Assuming the skin underneath the electrode and the optical sensor has a uniform 
strain field, skin strain is calculated as ΔL/L.  ΔL is proportional to the optical sensor 
output.  When the skin under the electrode is stretched, the sensor detects relative 
movement of the area underneath it due to skin strain of the adjacent area.  The sensor 




displacement in DSP.  In this manner, the skin strain is proportional to the sensor 














Stretched skin  
Figure 11. Illuminated skin surface area underneath the CMOS image sensor 
 
Figure 12 shows two images (Avago Technologies 2005) with image (b) take 
a short time after image (a), while there is relative movement between the sensor and 
the area beneath it.  The optical sensor integrated with a digital signal processor 
identified common features in sequential images to determine the direction and 





(a)      (b) 
 
Figure 12. The optical sensor identified common features in sequential images to 
determine the direction and amount of relative displacement of the area underneath 
the sensor.  Image (b) was take a short time after image (a), while there is relative 
movement between the sensor and the area beneath it (Avago Technologies 2005). 
 
3.2   Calibration of the Optical Skin Stretch Sensor  
To demonstrate the feasibility of using the optical sensor to measure soft material 
strain, experiments were carried out to calibrate the optical strain sensor performance 
in vitro.  An animal skin specimen was clamped and stretched in a controlled 
condition.  The experiment is illustrated in (b) 
Figure 13.  The optical sensor is an image sensor with a resolution 0.03175 
mm36.  The optical sensor is attached and fixed at one end of the specimen.  This is to 
ensure that there is no relative movement between the sensor and one edge of the 
fabric specimen.  The sensor is connected to a computer by a universal serial bus 
                                                 
36 The optical sensor’s resolution is its ability to detect spatial differences. In this study the sensor is 




(USB port).  The initial distance between the two inner sides of the clamp is recorded 
using a micrometer caliper.  The specimen is stretched step by step with the amount 
of elongation measured by a micrometer caliper.  The relationship of the strain 
calculated from the elongation amount and the sensor output is plotted in the 
computer to demonstrate the feasibility of using the optical sensor to measure soft 
material strain.   
Based on optical navigation technology, the sensor optically measures 
changes in position by sequentially acquiring 1500 surface images per second and 
mathematically determining the direction and magnitude of movement. The process 
overlays two sequential images and slides them around to a number of positions, until 
the best fit is found. The image capturing rate is fast enough so that sequential 
pictures overlap. The higher the image capturing rate, the higher the relative 
movement speed it can respond to (the maximum speed the optical sensor can 
respond to is proportional to the image capturing rate). For example, if the dimension 
of the optical sensor is 0.8mm*0.8mm, and the magnification factor is 1, the 
maximum speed the optical sensor can capture is 0.8mm/(1/1500s) = 1200mm/s. The 
sensor used in this study can detect up to 355.6mm/s, while the typical skin 
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Figure 13. In-vitro Calibration of the optical stretch sensor 
 
The sensor’s output position was recorded by a Delphi program.  The program 














key to store the data, as shown in Figure 14.  Let x and y be the sensor output - offset 
values in x and y directions.  Let x0 and y0 be the initial sensor output. Assuming the 




0 )()( yyxxS −+−=  
 
 
Figure 14. Cursor recording program 
 
Monoaxial tensile experiment was performed to calibrate the optical stretch sensor in-






Figure 15.  Static deformation was maintained during the experiment.  Two 
legs of a micrometer were attached to a forearm by adhesive tape.  The two legs were 
driven apart so as to exert tensile stress on the skin and extend the skin between the 
two legs.  One edge of the optical sensor was attached to the skin surface using 
double-sided adhesive tape, while the other end hanging above the skin.  The 
micrometer was used to stretch the skin and to measure the distance between the two 
legs.  The optical sensor output was recorded in the same computer program as 










Figure 15. In-vivo calibration 
 
The transfer function of the optical sensor establishes dependence between the 
optical sensor output S and skin strain s. A transfer function of a sensor can be any 
form. In this study, the in vitro and in vivo calibration results, as shown in Figure 16 
and Figure 17 respectively, demonstrated that a linear relationship was achieved 
between the sensor output and the amount of skin strain calculated from the 
elongation. The results demonstrate that the optical sensor can be used as a soft 
material strain sensor. The transfer function of the optical sensor can be written as  
S = bs  
where s is the skin strain calculated as the amount of elongation of the skin divided by 























































Figure 17. In vivo calibration 
 
3.3   Prototyping  
The optical strain sensor has been calibrated in vitro and investigated in terms 
of sensitivity and measurement range. Optical sensor integrated electrode is then 




The relationship between the optical sensor sensitivity / slope b and the 
distance between the fixed edge and the imaging field (mm) L is investigated.  The 
optical sensor output versus the skin strain was measured with a particular L value.  
The distance L was changed five times from 35.27 mm to 9.28 mm, and the 
experiment was repeated for each L.  The results are shown in Figure 18 and Table 1.  
It was obvious that the larger the L, the larger the sensitivity for measuring skin 
strain.  The relationship between the sensitivity and L is shown in Figure 19.  The 































Figure 18. Optical sensor output vs. skin strain with different L (distance between the 
fixed edge and the imaging field) 
 
 
Table 1.  Optical sensor sensitivity vs. L  
No. L (mm) Sensitivity b R2 
1 35.27 20.24 0.998 
2 28.54 16.64 0.996 
3 22.23 12.61 0.999 
4 15.78 8.63 0.996 




















Figure 19. Optical sensor slope / sensitivity vs. distance L 
 
Based on the results above, the sensitivity / slope b of the optical sensor can 
be represented by   
b = kL 
Where L is the distance between the fixed edge and the imaging field (mm); k 
is a factor depending on the sensor resolution.  
The optical sensor’s resolution can affect its sensitivity to measure skin strain. 
Theoretically, the larger the sensor resolution, the better the sensitivity for measuring 
skin strain. The sensor’s sensitivity to measure skin strain also depends on L (the 




Chapter 4: Adaptive Filtering Theory 
 
4.1   Introduction 
An adaptive filter is a digital filter that processes a signal by adaptively 
adjusting itself to the input signal.  This ability to operate in an unknown environment 
to track time variations of input statistics makes adaptive filters a powerful tool in 
signal processing and control applications.  In comparison, a non-adaptive filter has 
static filter coefficients, which require a priori information about the statistical 
characteristics of the input data and is not adequate to be applied for nonstationary 
inputs.   
Adaptive filters have been successfully applied in diverse fields including 
communications, radar, sonar, seismology and biomedical engineering.  When 
applying an adaptive filter, an input vector and a desired response are used to 
compute an estimate error, which is in turn used to control the values of a set of 
adjustable filter coefficients.   
Adaptive filters have four main classes of applications, including 
identification, inverse modeling, prediction, and interference or noise cancellation.  
Detailed description of these four applications can be referred to the book of Haykin 
(2001).  In this thesis work, adaptive filters are used for the purpose of noise 
cancellation, i.e., to subtract noise from a received signal in an adaptive controlled 




Adaptive noise canceling was initially applied by Bell Telephone Laboratories 
in echo cancellation on telephone circuits around 1965, with the speech signal itself 
utilized in performing the adaptation (Haykin 2001).  Widrow et al. (1975) developed 
the adaptive line enhancer in 1965 to eliminate 60-Hz interference in 
electrocardiography.   
Adaptive noise canceling is a method of estimating signals corrupted by some 
unknown and additive noise or interference, with the cancellation process being 
optimized.  This scheme operated on the outputs of a primary sensor and a reference 
sensor.  The primary sensor supplies a desired signal of interest buried in noise to the 
adaptive filter.  There are two assumptions here: (1) the signal and noise at the output 
of the primary sensor are uncorrelated; and (2) the signal at the output of the 
reference sensor is correlated with the noise component of the primary-sensor output.  
The noise is adaptively filtered and subtracted from the primary input to obtain the 
signal estimate.  In the adaptive noise canceling system, the system output serves as 
the error signal for the adaptive process.  With a proper algorithm, the filter can 
operate under changing conditions and readjust itself continuously to minimize the 
error signal (Thakor and Zhu 1991).     
Figure 20 shows the electrode-sensor system and adaptive filter structure to 
reduce ECG motion artifacts developed in this thesis work.  The method uses the 
corrupted ECG signal as a primary input and skin strain signal as a reference input, 
which is correlated with the noise in the primary input.  The system consists of a pair 
of electrodes, with an optical sensor on one electrode, an ECG amplifier and a 




strain signal u(n) is measured from an optical sensor incorporated in an electrode.  
The adaptive filter estimates noise in an adaptive manner and eliminates the additive 
noise y(n) through the noisy ECG resulting in an electronic signal e(n) with fewer 
motion artifacts.  The adaptive canceller tends to minimize the mean-square value of 
the overall output e(n), thereby causing the output be the best estimate of the desired 
signal in the minimum-mean-square error sense.  e(n) is in turn used to adjust the 
filter coefficients.  This is described in detail as follows. 
 
 
Figure 20. Electrode-sensor system and adaptive filter structure to reduce ECG 
motion artifacts 
 
Let s be the true ECG signal and a be the artifacts added to the true ECG 
signal.  d is the corrupted ECG signal given by d = s + a, and u is the skin strain 
signal from the optical sensor.  y is the estimate of the artifacts.  The system output / 
error e is defined as e = s + a – y.  The objective of the adaptive filtering is to 
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The smallest possible output power is E[e2] = E[s2].  When this is achieved, 
E[(a-y)2] = 0.  Therefore, y = a and e = s.  This means minimizing output power 
causes the output signal to be noise free (Widrow et al. 1975).  
Least-Mean-Squares (LMS) adaptive filter was applied in this study.  In this 
thesis work, all the artifacts are reduced offline in Matlab.  
 
4.2   Least-Mean-Squares Adaptive Filter 
The Least-Mean Squares (LMS) algorithm is an iterative technique for 
minimizing the mean squared error (MSE) between the primary and the reference 
inputs.  An adaptive filter W(n) can be represented as an M×1 array of filter 




















































W(n) is iteratively updated after each sample according to the following 
equations. 
)()()( nUnWny T=     (3) 
)()()( nyndne −=     (4) 
)()()()1( nenUnWnW μ+=+   (5) 
Where,  
n is the current time index 




u(n) is the optical sensor output at step n, served as a auxiliary input 
d(n) is the noisy ECG signal at step n, served as the desired response  
y(n) is the estimated artifacts at step n, served as the filtered output 
e(n) is the ECG signal with reduced artifacts at step n, served as the estimation 
error 
W(n) is an M×1 array of estimated filter coefficients at step n (If prior 
knowledge of the filter coefficients W(n) is available, use it to select an appropriate 
value for W(0), otherwise set W(0) = 0.) 
M is the order of the filter (filter length; number of taps) 








Chapter 5:  Adaptive Artifact Reduction 
 
5.1   Methodology    
The proposed sensor system and methodology can be used for either 
continuous ECG monitoring or ambulatory ECG monitors.  Figure 21 (a) illustrates 
the apparatus for the ECG recording and motion artifact removal system, with all the 
recorded data analyzed offline in a computer.  Figure 21 (b) shows the apparatus for 
ambulatory ECG recording and motion artifact reduction, with the adaptive filtering 
algorithm programmed in a microprocessor and the artifacts reduction processed 





























Figure 21. Apparatus for (a) ECG monitor; (b) ambulatory ECG monitor 
 
In this thesis, the artifacts reduction process was conducted offline with the 
adaptive filters programmed in Matlab.  Least-Mean-Squares (LMS) adaptive 
filtering algorithm, implemented in Matlab, has been applied in this study.  
 
5.2   Experiments 
Skin strain was recorded by optical sensor attached in the vicinity of an 
electrode.  Channel I and channel II ECG in standard clinical applications were 
recorded in this study under an IRB-approved protocol with a standard ECG amplifier 
(Harvard Apparatus ECG100C).  Channel I ECG was recorded as the potential 
difference between the two forearms, and the optical sensor was attached by double-
sided adhesive at the edge of the electrode on the left forearm.  Channel II ECG was 
recorded as the potential difference between the right forearm and the left leg, and the 
optical sensor was attached at the edge of the electrode on the right forearm. Figure 





The ECG sampling rate was 200Hz in this study, which allowed entire 
bandwidth of the skin surface ECG (0.05 to 100 Hz) to be captured. The ECG signal 
was amplified by 5000 and went through a high pass filter with a 0.5 Hz cutoff 
frequency.  Figure 24 shows the ECG amplifier, electrode and the optical sensor 
applied in this study.  Figure 25 shows the ECG recording software. Skin strain was 
measured by an optical sensor and recorded simultaneously with ECG. Skin strain 
was captured at the rate of 64 Hz, and then linearly interpolated to 200 Hz. ECG and 
skin strain measurements were programmed to start simultaneously by pressing one 
key in the keyboard. The optical sensor was attached by double-sided adhesive in the 
vicinity of the electrode on the left forearm.  In each case, artifacts were generated by 




























Figure 24. The ECG amplifier, electrodes and the optical sensor 
 
 
Figure 25. ECG recording software 
 
The optical sensor was connected to a computer by a USB cable.  The sensor 
output was recorded by pressing a key to activate a Delphi program, as shown in 
Figure 26.  Optical sensor output (X and Y offset values) and time are recorded for 
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x0 and y0 are initial optical sensor output - offset values in x and y directions.  
The assumption here is that the strain is one dimensional and uniformly distributed 
underneath the electrode.   
The optical sensor output was then linearly interpolated to 200 Hz.  The 
interpolated optical sensor output then went through a high pass filter with the cutoff 
frequency 1 Hz to eliminate the offline drift (Butterworth highpass filter, filter order 
is 8, passband edge frequency is 1 rads/sec).  The filtered optical sensor output signal 
and ECG signal were saved as data file to serve as the inputs of adaptive filters.   
 
 






5.3   ECG Artifacts Reduction 
Figure 27 shows the ECG signal and artifacts.  A typical ECG waveform is 
composed of a P wave, a QRS complex (which is comprised of Q, R and S waves), 
and a T wave, as shown in the upper plot of Figure 27.  The significant features of the 
waveform are the waves and their individual durations, and time intervals including 
the P-R, S-T and Q-T intervals (Webster 1998).  The bottom plot of Figure 27 is the 
ECG signal corrupted by skin stretch induced artifacts.  The artifacts have similar 
shape of the T waves.  
 

































Figure 27. ECG signal and artifacts 
 
Figure 28 shows the artifact reduction in a simple cardiac cycle of the ECG 
recording. The upper plot of Figure 28 is an artifact-free ECG segment recorded from 
a human subject. The bottom plot of Figure 28 shows a lead I ECG segment with 




filtering. It can be shown that the adaptive filter reduced the skin stretch induced 
artifacts, while keeping the useful waveforms, compared with the artifact-free ECG 
segment. 
 






































Figure 28. One cardiac cycle of lead I ECG artifact reduction  
 
Figure 29 shows the artifact reduction results of a 30-second lead I ECG 
recording.  The four traces in Figure 29 are optical sensor output which indicates the 
amount of skin strain, estimated artifacts by the adaptive filter, ECG signal before 
artifact reduction, and ECG signal after artifact reduction.  The first three cardiac 
cycles were artifact-free.  Comparing artifact-free ECG in the first three cardiac 
cycles with the following noisy ECG, it is shown in Figure 29 that a large amount of 













































ECG with artifacts 
ECG after artifact reduction
 
Figure 29. Artifact reduction of a 30-second lead I ECG data  
 
Lead II ECG recording and skin strain signal were shown in Figure 30.  The 
first two cardiac cycles were artifact-free.  The locations of artifacts were identified 
by red arrows.  Different from artifacts in lead I ECG, which are mainly adding a 
positive potential signal to the ECG signal, artifacts in lead II ECG generally adding a 
negative potential signal to the ECG data.  This is because the potential on the right 
forearm is smaller than that of the left leg, and skin stretch on the right forearm 
causes its potential to increase, the acquired ECG signal showed a significant 
decrease when the skin around the electrode was stretched.  Therefore, the 10 large 
negative peaks identified by red arrows in the second trace of Figure 30 were artifacts 
















































































Figure 30. Lead II ECG and skin strain induced artifacts  
 
Figure 31 shows the artifacts reduction results of the lead II ECG signal.  In 
Figure 31, the third trace (ECG signal corrupted by artifacts) contained 10 negative 
peaks which were skin strain induced artifacts during 7 seconds.  In the fourth trace 
(estimated ECG after noise removal), all the 10 large negative peaks were eliminated 
except for the first one, while the positive ECG features in the second trace were kept 
the same.  The results demonstrated that the proposed sensor systems and method can 






























































































Figure 31. Lead II ECG artifacts reduction 
 
It was observed during measurement that different human subjects have 
different ECG amplitudes and skin stretch induced potentials. This observation is 
consistent with Odman’s study (1981, 1982), which indicated that measured skin 
stretch potentials showed large individual variations. Odman’s data showed that for 
stretched skin potentials, standard deviations are in the range of 32%-94% of the 
corresponding mean values.   
For some individuals who have stronger ECG signal, skin stretch induced 
artifacts can be comparatively smaller. For other individuals who have weaker ECG 




signal. One example is illustrated in Figure 32. Figure 32 (a) and Figure 32 (b) are 
recorded from human subject a and b, respectively. In both (a) and (b), the upper plot 
is the artifact-free ECG, and the bottom plot is the ECG corrupted by skin stretch 
induced artifacts.  
In Figure 32 (a), the peak value of subject a’s ECG QRS complex is 
approximately 0.6 mV, while skin stretch induced artifacts have the amplitude of 0.1-
0.2 mV, which is comparable to the amplitudes of the T waves. In Figure 32 (b), the 
peak value of subject b’s ECG QRS complex is less than 0.1 mV, while skin stretch 
induced artifacts have the amplitude of approximately 0.2 mV, which is larger than 
the QRS complex amplitude. Even though the amplitudes of ECG and skin strain 
induced voltage are different from person to person, skin strain induced ECG artifacts 
can be reduced by this method, since the filters adaptively build the equation between 
skin strain signal and ECG motion artifacts. In other words, the filter adapts itself to 
describe the relationship between skin strain signal and ECG artifacts for a particular 









































































Figure 32. (a) Artifact-free ECG and ECG with artifacts for subject a; (b) Artifact-





During the experiments, it was observed that even for the same human 
subject, stretching the skin may not necessarily induce ECG artifacts. In other words, 
a subject’s skin stretch induced artifact may be obvious for a certain period of time, 
and disappear for another period of time. The reason hasn’t been clearly reported in 
literature. Odman (1981) observed that time sequences for the skin stretch potentials 
vary individually. Studies of Tam and Webster (1977), and Burbank and Webster 
(1978) mainly focused on the influence of abrasion and of electrolyte concentration 
on skin induced motion artifact in biopotential recording. Thakor and Webster (1978) 
hypothesized that the skin potential arises from a constant current source called 
‘injury current’ flowing through the extracellular resistance. de Talhouet and Webster 
(1996) validated Thakor’s model through experiments and hypothesized that another 
possible explanation would be a direct influence of the stretch on the active metabolic 
process. Up to now there is no widely accepted explanation on why skin strain 
induces skin voltage change. Since adaptive filters describes a dynamic relationship 
between skin strain signal and ECG artifacts, this phenomena is not a concern in this 
study. For the time period when stretching skin causes no or little artifacts, the filter 
weights will be adjusted to zero or close to zero, to indicate that artifacts are 
negligible in this time frame. 
Another alternative of our approach is that a two dimensional analysis can be 
conducted. This is necessary because skin is an anisotropic material. Skin tends to be 
much stiffer along Langer’s lines37 rather than across them. Concerning electrical 
properties, according to Odman’s (1982) observations, it can be concluded that skin 
presents isotropic electrical properties, meaning that the skin stretch induced artifacts 
                                                 




only depend on the amount of skin strain, but don’t depend on skin stretch directions. 
In this study the optical sensor output S indicates the skin strain magnitude as a 
function of time, without the information of skin strain directions.  
 
5.4   Artifact Reduction Quantification 
 
At this time, there is no standard method to quantify the amount of artifacts 
eliminated. Thus signal processing methods were used in this study to quantify the 
amount of artifacts eliminated. A 30-second artifact-free ECG signal was recorded 
with the human subject at rest. A 30-second noisy ECG was recorded on the same 
human subject right after the noisy-free ECG, so that the heart rate was approximately 
the same and therefore the noisy-free ECG data set can be used as an “ideal” 
reference. 
The L2 norm of the noisy ECG data and the data after artifact removal was 
calculated, was used as the metric for noise reduction. The more artifacts remain in 










A percentage improvement statistic was calculated as 


































Where L2_before is the L2-norm of the noisy ECG signal; L2_after is the L2-norm 
of the ECG signal after artifact reduction; L2_ideal is the L2-norm of the artifact-free 
ECG signal.   
A 30-second ECG signal contained approximately 50 cardiac cycles. It was 
found that the artifact reduction percentage calculated using 10-second ECG signals 
was approximately the same as that calculated by using 30-second ECG signals. Thus 
a 30-second ECG signal is considered capable of providing accurate results for 
artifact reduction percentage analysis. 
Table 2 shows the artifact reduction performance of lead I ECG.  Three 
recordings of lead I ECG were recorded for each of three individuals.  Every 
recording lasts 30 seconds, i.e., 6000 data points.  As mentioned in section 5.2, 
artifacts were generated by intentionally stretching the skin on the left forearm.  The 
filter order was set as 10, and the initial filter coefficients were set as zero.  The 
results showed that on average of the nine 30-second recordings, LMS can reduce 
83% of motion artifacts.  
 
Table 2. Artifact reduction results of lead I ECG  

















The difference in artifact reduction performance for different individuals can 
be attributed to shape feature difference of the skin area where the optical sensor is 
attached. Non-flat attaching surface or larger curvature of the sensor mounting spot 
can cause the optical sensor to be out of focus during motions, which can lead to 
inaccurate sensor output for some time frame. To ensure a proper sensor attachment 
to the skin surface during motions is found to be the key challenge in this study, 
which otherwise can cause signal instability of the optical sensor output. Non-flat 
skin / body surface, vertical deformation of the skin, or vertical movement of the 
sensor may cause the image to lose focus. Plane imaging should be maintained to 
satisfy the plane-strain state. A further device miniaturization is suggested to ensure 
better attachment on different geographic skin surface. 
 
5.5   Tests of Ambulatory Conditions 
To further assess the artifact reduction performance of the apparatus and 
method for ambulatory ECG monitors, the sensor system was tested under various 




the arm vertically, waving the arm horizontally and slightly stretching the upper 
chest. A modified lead I ECG was recorded during ambulatory testing.  Electrode 
sites and the optical sensor site were shown in Figure 33.  Two electrodes were 
attached to the subject’s upper chest, with one on the left and one on the right.  The 
optical sensor was attached in the vicinity of the electrode on the upper left chest.   
 
 
Figure 33.  Ambulatory testing setup 
 
In total there were 15 recordings made from one human subject. Every 
recording lasts 30 seconds.  Artifacts reduction performance of ambulatory ECG was 
quantified by L2 Norm, with the results shown in Table 3.  The filter order was set as 
10, and the initial filter coefficients were set as zero.  On average, the LMS filter 
reduced 85% of the artifacts. The worst artifact performance can be attributed to non-




sensor that may cause the image to lose focus. The worse case was found when the 
subject horizontally waved the left arm, which caused part of the optical sensor to lift 
from the skin surface. However, even for this worst case, the method achieved an 
artifact reduction of 43%. To ensure a proper sensor attachment to the skin surface 
during motions, device miniaturization is suggested. 
 
Table 3.  Artifact reduction results of ambulatory testing 































Average (standard deviation) 84.55 (19.26) 
 
It should be noted that even though this method can reduce 55-81% artifacts 
under running conditions, since the total amount of noise is much larger than other 
conditions, the running ECG after artifact reduction is still quite noisy (see 
Appendices). Under running conditions it is more challenging to ensure the optical 
sensor signal stability and accurately capture the skin strain data. So even if this 
method can reduce more than half of the total artifacts under running conditions, the 
large amount of remaining noise still corrupts the ECG signal, and makes this method 
less effective under running conditions compared with other conditions.   
Figure 34 shows the artifact reduction results of a 30-second ambulatory ECG 
test. The data was recorded as the subject stretched the upper chest (recording 1 in 
Table 3). The first few cardiac cycles were artifact-free (in the first 3.6 seconds), 
when the subject was at rest. Trace 1 to 4 are the optical sensor output, estimated 
artifacts, ECG before artifact reduction, and ECG after artifact reduction, 
respectively. The optical sensor output indicates the subject’s motion as he repeatedly 
stretched and relaxed his chest, with each peak corresponding to a stretch. In trace 3 
of Figure 34, motion artifacts were identified with their locations marked by arrows. 
The artifacts were identified since their peak amplitudes were generally three times 
larger a typical T wave peak amplitude, which is 0.058 ± 0.005 mV for this subject. 
The majority of the artifacts were eliminated after adaptive filtering (trace 4 in Figure 
34), although a few remained in ECG (trace 4 in Figure 34). The L2-norm calculation 




Artifact reduction performance for the data in Figure 34 was analyzed cycle 
by cycle, as shown in Table 4. There were 50 cardiac cycles in this 30-second ECG 
data. In the analysis, the maximum positive value between the two adjacent QRS 
complex38 in each cardiac cycle was recorded. The artifacts have similar 
morphologies of T waves. Since T wave peak value is the maximum positive value 
between two adjacent QRS complex in an artifact-free cardiac cycle, measuring the 
maximum positive value between every two QRS complex and comparing it to 
artifact-free T wave peak value can give us insights of whether the wave is an artifact, 
as the artifacts have larger amplitudes than T waves. Similarly, we can find how well 
the artifact is reduced. A standard artifact-free T wave peak value was calculated to 
be 0.0575 mV, by averaging the T wave peak values in the first 4 artifact-free cardiac 
cycles.  Let T0 be the standard artifact-free T wave peak value, and let Ti be the 
positive peak value between two adjacent QRS complex in any given cardiac cycle, 
the noise is defined as a percentage of:  
 
Noise = (Ti - T0)/ T0 *100, (i = 1 to 50)  
 
The artifact reduction for each cardiac cycle is defined as the ratio of noise 
before artifact reduction and noise after artifact reduction (*100). The artifact 
reduction in the ECG of each cardiac cycle was calculated over 39 cardiac cycles in a 
30-second record, as shown in Table 4 (For the other 11 cardiac cycles, no artifacts 
were generated). It can be concluded that artifacts were greatly reduced (reduced 
more than 60%) for some cardiac cycles. But for other cardiac cycles the artifact 
                                                 
38 In every cardiac cycle there is a P wave, a QRS complex, and a T wave. QRS complex, consisted of 
the Q, R, and S waves, is caused by ventricular depolarization. The duration is normally 0.06 to 0.1 




reductions were relatively small (reduced less than 20% of the artifacts). This 
indicated that adaptive filtering algorithm does reduce but can’t totally eliminate the 
motion artifacts. For a few cardiac cycles, the artifact reduction percentage was 
calculated to be larger than 100%, which means that the filter not only reduced 
artifacts, but also eliminated certain amount of true ECG signals. 
 
 












































ECG after artifact reduction
 
Figure 34. Ambulatory ECG motion artifact reduction (recording 1: subject is slightly 
stretching the upper chest)  
 
Table 4.  Artifact reduction results cycle by cycle (Recording 1 of ambulatory testing: 
subject is slightly stretching the upper chest) 





< 0  10 (25.6%) 
0-20 3 (7.7%) 
20-40 3 (7.7%) 
40-60 3 (7.7%) 
60-80 5 (12.8%) 
80-100 5 (12.8%) 
100-120 6 (15.4%) 
>120 4 (10.3%) 
 
 
Figure 35 shows the artifact reduction results for another 30-second 
ambulatory ECG when the subject was raising the left arm (recording 6 in Table 3). 
The first few cardiac cycles were artifact-free, when the subject was at rest. Almost 
all the artifacts were successfully picked up by the adaptive filter and subtracted from 
the noisy ECG. The L2-norm calculation shows that the artifacts have been reduced 

















































ECG after artifact reduction
 
Figure 35. Ambulatory ECG motion artifact reduction (recording 6: subject is raising 
the left arm) 
 























Figure 36. Ambulatory ECG motion artifact reduction (recording 7) 
 
The adaptive filter won’t add “wrong” data to the corrupted ECG. Since it 
takes some time for LMS filters to converge, during this period artifacts may not be 
greatly reduced. Take Figure 35 as an example: the first four cardiac cycles are 
artifact-free, and the estimated artifacts are zero for this period of time. The first 
artifact was generated between 4-5 second. This artifact wasn’t reduced after artifact 
reduction, as it can still be clearly identified after artifact reduction (trace 4 of Figure 
35). The reason is that during this period the LMS filter was in the training process 
and the filter was trying to “track” the artifacts. After that, the artifacts generated in 5-
30 second have been reduced from ECG signal (trace 4 of Figure 35). Another 
concern is that the filter may take away some portion of good ECG signals. In Figure 
35, the QRS complex amplitudes may be changed after artifact reduction, compared 
with artifact-free ECG signals. But the general morphologies of QRS complex and T 
waves are kept or recovered after artifact reduction. For P waves, their amplitudes are 
so small that they can be easily buried in the existing noise generated by muscle 
contractions. The high frequency muscle contraction induced noise can be reduced by 
a high pass filter.    
Figure 37 shows the LMS filter weights change over time.  Since there is no 
prior knowledge about the statistics of the true artifacts, all the initial value of the 
weights were set as zero, which is a general procedure in signal processing.  In the 
first a few seconds of this recording, there were no motion artifacts generated.  The 




automatically adjusts its weights, which makes adaptive filter different from a fixed 
filter.  The coefficients of a fixed filter won’t change over time.  The results 
demonstrated that the skin stretch induced motion artifacts have dynamic statistical 
characteristics. 
 











Figure 37. LMS filter weights 
 
The sensitivity of the filter performance was analyzed by changing the filter 
order and step-size parameter.  The results were shown in Figure 38.  For the same 
filter step-size parameter, the larger the filter order M is, the better the artifact 
reduction performance.  The artifact reduction can improve 2-5% more when 
increasing M by 1.  For the same filter order, the larger the step size parameter, the 




Beyond this maximum value will cause the filter fail to reduce artifacts.  This upper 
boundary can be defined by μ < 2 / (MSmax), where Smax is the maximum value of the 






































Figure 38. LMS filter performance  
 
For each filter order M, there is a maximum noise reduction percentage when 
changing the step size parameter.  Increasing the filter order slightly improves the 
filter performance, as shown in Figure 39.  Mathematically, this can be explained that 
the current value of skin strain plays a more important role in artifacts estimation than 




quite fast so that history of the skin strain signal is not as important as the current 
value.   
 
 
Figure 39. LMS filter performance vs. filter order 
 
Artifact reduction performance varies in different types of motion. This is 
because the optical sensor is easier to go out of focus during motions that induce 
more vertical movements of the sensor. Time frame 10-12 second of Figure 34 was 
zoomed in Figure 40 (a). An artifact exists between 10-10.5 second (trace 3 of Figure 
40 (a)), and hasn’t been reduced after going through artifact reduction (trace 4 of 
Figure 40 (a)). This artifact has a peak amplitude of 0.36 mV, which is much larger 
than the T wave peak amplitude (0.06 mV). Trace 4 of Figure 40 (a) indicates that the 
skin strain signal was failed to be picked up by the optical sensor (A captured skin 
strain will result in optical sensor output to be approximately 50). On the other hand, 
in the top trace of Figure 35, the optical sensor captured all the skin strain signal 
while the subject was raising the arm.   





















Residual motion artifacts can also be due to the characteristic change of skin 
electrophysiology during stretching. Thus there is no constant correlation between 
skin stretch detected by optical sensor and the amplitude of the ECG artifacts. The 
adaptive filter has to keep finding converging solutions in this dynamic environment. 
Time frame 20-26 seconds of Figure 34 was zoomed in in Figure 40 (b). Between 24 
and 25 seconds, skin stretch was in similar amounts of amplitudes as those between 
23 and 24 seconds, while artifacts were larger. If the adaptive filter changed its 
solution according to the dynamic changes in inputs before the artifacts were fully 
picked, residual artifacts were left.  
During the experiments, it was observed that stretching the skin did not 
always induce ECG artifacts. In other words, a subject’s skin stretch induced artifacts 
may be larger than the ECG signal for a certain period of time, and then disappear 
over another time frame. The reason hasn’t been clearly reported in the literature, 
although. Odman (1981) observed that time sequences for the skin stretch potentials 
vary individually.  
Up to now there is no widely accepted explanation on why skin strain induces 
skin voltage change. Since adaptive filters captures the dynamic relationship between 
skin strain signal and ECG artifacts, the phenomena discussed above is not a concern. 
For the time period when stretching skin causes no or little artifacts, the filter weights 
are quickly adjusted to zero or close to zero, indicating that artifacts are negligible in 





Figure 40. Ambulatory ECG motion artifact reduction. ECG was recorded 
when the subject is slightly stretching the upper chest (recording 1).  First trace: skin 
strain signal; second trace: estimated artifacts; third trace: ECG with artifacts; fourth 
trace: ECG after artifact reduction 
 
The artifact reduced ECG can be used in applications such as heart rate 
measurement and arrhythmia detection (Thakor and Zhu 1991). In some cardiac 
cycles, artifacts reduction recovered ECG morphology. Figure 41 shows that in 
artifact corrupted ECG, T waves were buried in artifacts: artifacts last approximately 
0.6 second and have a peak value of 0.2 mV, while T wave only last about 






































      









































approximately 0.2 seconds, and have a peak value of 0.06mV. ECG after artifact 
reduction has similar morphology to that of the artifact-free ECG, which indicates a 
good recovery.  
 
 
Figure 41. Ambulatory ECG motion artifact reduction (recording 6: subject is 
raising the left arm) 
 
Artifact reduction performance can also be analyzed in frequency domain. 
Fast Fourier transform was conducted for ECG signals before and after artifact 
reduction (second and third trace of Figure 42). Frequency components of artifact free 
ECG was the reference (top trace of Figure 42). The majority of frequency 
 





























ECG after artifact reduction











components of skin stretch induced artifacts are below 2 Hz, which overlaps with 
ECG frequency (1.7 Hz peak), as seen in trace two of Figure 42. After artifact 
reduction, this part was largely reduced, as can be seen in the third trace of Figure 42. 
Note that since artifact-free ECG and ECG with artifacts were not recorded 
simultaneously, the heart rates when the two signals were recorded were slightly 
different. This explains that the frequency components shifted 0.3-0.5 Hz between the 
top trace and the bottom two traces.  
  
 
Figure 42. Frequency domain analysis of artifact-free ECG (first trace), ECG 
with artifacts (second trace), and ECG after artifact reduction (third trace). The top 





















trace is recorded when the subject was at rest. The second and third traces were taken 
when the subject was raising the left arm. 
 
5.6   Conclusions 
A wearable sensor system to non-invasively reduce ECG motion (skin-stretch) 
artifacts with an optical sensing technique and adaptive filtering has been developed 
and demonstrated. Calibration results demonstrated that the optical sensor can be used 
as a non-invasive wearable skin strain sensor with high linearity (R2 = 0.98).  
ECG is widely used in standard clinical practice. During stress test, ECG is 
recorded while the patient is moving (walking, running) on a treadmill. The purpose 
of this test is to diagnose coronary artery disease, determine the cause of chest pain 
and exercise capacity of the heart, and to identify rhythm disturbances. The heart rate 
and morphologies of the ECG waveforms are important for diagnosis. Ambulatory 
ECG monitoring allows a patient to wear a recorder and continuously record ECG for 
24 to 48 hours; or for a few months, and trigger the ECG recording upon symptoms. 
The purpose of ambulatory ECG recording is to detect infrequent arrhythmia which 
may not be detected in a doctor’s office. Significant features including the ECG 
waves’ individual durations, and time intervals including the P-R, S-T and Q-T 
intervals are analyzed offline for arrhythmia diagnosis. Other than that, for patients 
whose heart beats needs to be continuously monitored during their hospital stay. 
Accurate detection of heart rate and rhythm is necessary, and false alarms can be 




applications for artifact reduction. In addition, the system and method can be further 
applied to motion artifact reduction of other biopotential recordings.  
Experimental results demonstrated that this sensor system and method can 
effectively remove skin strain induced artifacts from ECG signals. On average, this 
wearable sensor system and method can reduce 85% of motion artifacts under various 
types of ambulatory conditions, such as walking, raising the arm, and running. 
Increasing the filter order slightly improves the filter performance. Even in the worst 
case, the method can achieve artifact reduction by 43%, which was caused by non-flat 
skin / body surface, vertical deformation of the skin, or vertical movement of the 
sensor that may cause the image to lose focus. Signal stability of the optical sensor 
output is currently the key challenge of this system and method. Device 
miniaturization is suggested to ensure a proper sensor attachment to the skin surface 
during motions.   
Correctly measuring skin stretch in-vivo is a complicated task. Using the 
optical sensor to detect skin strain can be applied in other applications, as currently 
there is no successful method to accurately measure soft tissue strain in a wearable 
manner. Examples include research on skin mechanical properties for dermatologists 
and biologists in medicine, evaluation of skin disease and aging, and skin deformation 
assessment. The optical strain sensor can be used as a noninvasive, simple and cost 
effective skin / soft tissue strain sensor. Other advantages include high resolution, 
high sampling rate, and the potential to be used to measure local skin strain in real 




Chapter 6:  Contributions 
 
The contributions from this thesis are:  
• Identified the limitations in existing and emerging non-invasive ambulatory 
cardiovascular monitoring techniques to improve the device design and 
wearability  
• Developed a method that utilizes measured skin strain signal as a reference 
input in adaptive filtering to reduce ECG motion artifacts 
• Demonstrated the feasibility of using an optical technique as a wearable skin 
strain sensor for non-invasive ambulatory monitoring 
• Demonstrated that the system and method that utilizes optical sensing and 
adaptive filtering technique can reduce skin stretch induced artifacts  
• Demonstrated that the wearable system and method can reduce motion 
artifacts in daily activities for ambulatory ECG monitoring 
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15 ambulatory ECG recordings before and after artifact reduction 
 












































ECG after artifact reduction
 
Ambulatory ECG motion artifact reduction (recording 1: subject is slightly stretching 
the upper chest); top trace: optical sensor output; second trace: artifacts estimated by 
the adaptive filter; third trace: ECG signal corrupted by artifacts; bottom trace: ECG 












































Ambulatory ECG motion artifact reduction (recording 2: subject is slightly stretching 
the upper chest); top trace: optical sensor output; second trace: artifacts estimated by 
the adaptive filter; third trace: ECG signal corrupted by artifacts; bottom trace: ECG 












































Ambulatory ECG motion artifact reduction (recording 3: subject is horizontally 
waving the left arm); top trace: optical sensor output; second trace: artifacts estimated 
by the adaptive filter; third trace: ECG signal corrupted by artifacts; bottom trace: 












































Ambulatory ECG motion artifact reduction (recording 4: subject is horizontally 
waving the left arm); top trace: optical sensor output; second trace: artifacts estimated 
by the adaptive filter; third trace: ECG signal corrupted by artifacts; bottom trace: 












































Ambulatory ECG motion artifact reduction (recording 5: subject is horizontally 
waving the left arm); top trace: optical sensor output; second trace: artifacts estimated 
by the adaptive filter; third trace: ECG signal corrupted by artifacts; bottom trace: 


















































ECG after artifact reduction
 
Ambulatory ECG motion artifact reduction (recording 6: subject is raising the left 
arm); top trace: optical sensor output; second trace: artifacts estimated by the adaptive 
filter; third trace: ECG signal corrupted by artifacts; bottom trace: ECG signal after 











































Ambulatory ECG motion artifact reduction (recording 7: subject is raising the left 
arm); top trace: optical sensor output; second trace: artifacts estimated by the adaptive 
filter; third trace: ECG signal corrupted by artifacts; bottom trace: ECG signal after 











































Ambulatory ECG motion artifact reduction (recording 8: subject is raising the left 
arm); top trace: optical sensor output; second trace: artifacts estimated by the adaptive 












































Ambulatory ECG motion artifact reduction (recording 9: subject is walking); top 
trace: optical sensor output; second trace: artifacts estimated by the adaptive filter; 













































Ambulatory ECG motion artifact reduction (recording 10: subject is walking); top 
trace: optical sensor output; second trace: artifacts estimated by the adaptive filter; 















   






























Ambulatory ECG motion artifact reduction (recording 11: subject is walking); top 
trace: optical sensor output; second trace: artifacts estimated by the adaptive filter; 













































Ambulatory ECG motion artifact reduction (recording 12: subject is walking); top 
trace: optical sensor output; second trace: artifacts estimated by the adaptive filter; 












































Ambulatory ECG motion artifact reduction (recording 13: subject is running); top 
trace: optical sensor output; second trace: artifacts estimated by the adaptive filter; 













































Ambulatory ECG motion artifact reduction (recording 14: subject is running); top 
trace: optical sensor output; second trace: artifacts estimated by the adaptive filter; 













































Ambulatory ECG motion artifact reduction (recording 15: subject is running); top 
trace: optical sensor output; second trace: artifacts estimated by the adaptive filter; 
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